<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN"  "JATS-archivearticle1-mathml3.dtd"><article article-type="research-article" dtd-version="1.2" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn pub-type="epub" publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">72266</article-id><article-id pub-id-type="doi">10.7554/eLife.72266</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Medicine</subject></subj-group></article-categories><title-group><article-title>ACE2 pathway regulates thermogenesis and energy metabolism</article-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes" id="author-248312"><name><surname>Cao</surname><given-names>Xi</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-5447-6766</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="other" rid="fund3"/><xref ref-type="other" rid="fund5"/><xref ref-type="other" rid="fund4"/><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" equal-contrib="yes" id="author-248313"><name><surname>Shi</surname><given-names>Ting-Ting</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" equal-contrib="yes" id="author-248314"><name><surname>Zhang</surname><given-names>Chuan-Hai</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-7644-2436</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-51138"><name><surname>Jin</surname><given-names>Wan-Zhu</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-248315"><name><surname>Song</surname><given-names>Li-Ni</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-248316"><name><surname>Zhang</surname><given-names>Yi-Chen</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-248317"><name><surname>Liu</surname><given-names>Jing-Yi</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-248318"><name><surname>Yang</surname><given-names>Fang-Yuan</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con8"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-207692"><name><surname>Rotimi</surname><given-names>Charles N</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="con9"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-10524"><name><surname>Xu</surname><given-names>Aimin</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="con10"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-129131"><name><surname>Yang</surname><given-names>Jin-Kui</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-5430-2149</contrib-id><email>jkyang@ccmu.edu.cn</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund2"/><xref ref-type="fn" rid="con11"/><xref ref-type="fn" rid="conf2"/></contrib><aff id="aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/013xs5b60</institution-id><institution>Beijing Key Laboratory of Diabetes Research and Care, Department of Endocrinology, Beijing Diabetes Institute, Beijing Tongren Hospital, Capital Medical University</institution></institution-wrap><addr-line><named-content content-type="city">Beijing</named-content></addr-line><country>China</country></aff><aff id="aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00t9vx427</institution-id><institution>Department of Physiology, UT Southwestern Medical Center at Dallas</institution></institution-wrap><addr-line><named-content content-type="city">Dallas</named-content></addr-line><country>United States</country></aff><aff id="aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/034t30j35</institution-id><institution>Key Laboratory of Animal Ecology and Conservation Biology, Institute of Zoology, and State Key Laboratory of Brain and Cognitive Sciences, Institute of Biophysics, Chinese Academy of Sciences</institution></institution-wrap><addr-line><named-content content-type="city">Beijing</named-content></addr-line><country>China</country></aff><aff id="aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01cwqze88</institution-id><institution>Center for Research on Genomics and Global Health, National Human Genome Research Institute, National Institutes of Health</institution></institution-wrap><addr-line><named-content content-type="city">Bethesda</named-content></addr-line><country>United States</country></aff><aff id="aff5"><label>5</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/02zhqgq86</institution-id><institution>State Key Laboratory of Pharmaceutical Biotechnology, Department of Medicine, University of Hong Kong</institution></institution-wrap><addr-line><named-content content-type="city">Hong Kong</named-content></addr-line><country>China</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Napoli</surname><given-names>Nicola</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/04gqx4x78</institution-id><institution>Campus Bio-Medico University of Rome</institution></institution-wrap><country>Italy</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Isales</surname><given-names>Carlos</given-names></name><role>Senior Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/012mef835</institution-id><institution>Medical College of Georgia at Augusta University</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group><author-notes><fn fn-type="con" id="equal-contrib1"><label>†</label><p>These authors contributed equally to this work</p></fn></author-notes><pub-date date-type="publication" publication-format="electronic"><day>11</day><month>01</month><year>2022</year></pub-date><pub-date pub-type="collection"><year>2022</year></pub-date><volume>11</volume><elocation-id>e72266</elocation-id><history><date date-type="received" iso-8601-date="2021-07-16"><day>16</day><month>07</month><year>2021</year></date><date date-type="accepted" iso-8601-date="2022-01-09"><day>09</day><month>01</month><year>2022</year></date></history><pub-history><event><event-desc>This manuscript was published as a preprint at .</event-desc><date date-type="preprint" iso-8601-date="2021-08-10"><day>10</day><month>08</month><year>2021</year></date><self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2021.08.10.455823"/></event></pub-history><permissions><ali:free_to_read/><license xlink:href="http://creativecommons.org/publicdomain/zero/1.0/"><ali:license_ref>http://creativecommons.org/publicdomain/zero/1.0/</ali:license_ref><license-p>This is an open-access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">Creative Commons CC0 public domain dedication</ext-link>.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-72266-v4.pdf"/><self-uri content-type="figures-pdf" xlink:href="elife-72266-figures-v4.pdf"/><abstract><p>Identification of key regulators of energy homeostasis holds important therapeutic promise for metabolic disorders, such as obesity and diabetes. ACE2 cleaves angiotensin II (Ang II) to generate Ang-(1-7) which acts mainly through the Mas1 receptor. Here, we identify ACE2 pathway as a critical regulator in the maintenance of thermogenesis and energy expenditure. We found that ACE2 is highly expressed in brown adipose tissue (BAT) and that cold stimulation increases ACE2 and Ang-(1-7) levels in BAT and serum. <italic>Ace2</italic> knockout mice (<italic>Ace2<sup>-/y</sup></italic>) and <italic>Mas1</italic> knockout mice (<italic>Mas1<sup>-/-</sup></italic>) displayed impaired thermogenesis. Mice transplanted with brown adipose tissue from <italic>Mas1</italic><sup>-/-</sup> display metabolic abnormalities consistent with those seen in the <italic>Ace2</italic> and <italic>Mas1</italic> knockout mice. In contrast, impaired thermogenesis of <italic>Lepr<sup>db/db</sup></italic> obese diabetic mice and high-fat diet-induced obese mice were ameliorated by overexpression of <italic>Ace2</italic> or continuous infusion of Ang-(1-7). Activation of ACE2 pathway was associated with improvement of metabolic parameters, including blood glucose, lipids, and energy expenditure in multiple animal models. Consistently, ACE2 pathway remarkably enhanced the browning of white adipose tissue. Mechanistically, we showed that ACE2 pathway activated Akt/FoxO1 and PKA pathway, leading to induction of UCP1 and activation of mitochondrial function. Our data propose that adaptive thermogenesis requires regulation of ACE2 pathway and highlight novel potential therapeutic targets for the treatment of metabolic disorders.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>ACE2</kwd><kwd>angiotensin-(1-7)</kwd><kwd>obesity</kwd><kwd>brown adipose tissue</kwd><kwd>diabetes</kwd><kwd>thermogenesis</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Mouse</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001809</institution-id><institution>National Natural Science Foundation of China</institution></institution-wrap></funding-source><award-id>81930019</award-id><principal-award-recipient><name><surname>Yang</surname><given-names>Jin-Kui</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001809</institution-id><institution>National Natural Science Foundation of China</institution></institution-wrap></funding-source><award-id>81561128015</award-id><principal-award-recipient><name><surname>Yang</surname><given-names>Jin-Kui</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001809</institution-id><institution>National Natural Science Foundation of China</institution></institution-wrap></funding-source><award-id>81670774</award-id><principal-award-recipient><name><surname>Cao</surname><given-names>Xi</given-names></name></principal-award-recipient></award-group><award-group id="fund4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001809</institution-id><institution>National Natural Science Foundation of China</institution></institution-wrap></funding-source><award-id>82070850</award-id><principal-award-recipient><name><surname>Cao</surname><given-names>Xi</given-names></name></principal-award-recipient></award-group><award-group id="fund5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100004826</institution-id><institution>Beijing Natural Science Foundation</institution></institution-wrap></funding-source><award-id>7162047</award-id><principal-award-recipient><name><surname>Cao</surname><given-names>Xi</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>A series of functional assays in mouse models and primary brown adipocytes confirm that the ACE2 pathway regulates glucose and lipid homeostasis, and maintains thermogenesis and systemic energy metabolism by both the Akt and PKA signaling.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Energy imbalance and the associated metabolic syndromes have become a worldwide public health problem. Thus, identifying factors that can stimulate energy expenditure is instrumental to the development of therapeutics to reduce obesity associated disorders that affect over 10% of the world population (<xref ref-type="bibr" rid="bib9">Dong et al., 2018</xref>). In the renin-angiotensin system (RAS), angiotensin-converting enzyme 2 (ACE2) cleaves angiotensin II (Ang II) to generate angiotensin-(1-7) (Ang-(1-7)). Ang-(1-7) is a heptapeptide hormone which acts mainly through G-protein-coupled receptor Mas1 (<xref ref-type="bibr" rid="bib28">Santos et al., 2003</xref>). ACE2-Ang-(1-7)-Mas1 pathway works as a negative regulator of ACE-Ang II pathway in multiple disease states (<xref ref-type="bibr" rid="bib6">Clarke and Turner, 2012</xref>).</p><p>Our group focused on ACE2 originated from concerns of severe acute respiratory syndrome (SARS) in 2003. Ambient hyperglycemia occurred very early in SARS patients and was an independent predictor for death and morbidity in SARS patients (<xref ref-type="bibr" rid="bib38">Yang et al., 2006</xref>). Interestingly, ACE2 is the functional receptor for SARS coronavirus (<xref ref-type="bibr" rid="bib14">Lavoie and Sigmund, 2003</xref>). We reported that <italic>Ace2</italic> knockout (<italic>Ace2</italic><sup>-/y</sup>) mice exhibited progressive impairments in glucose tolerance indicating that ACE2 is a potential new target for the treatment of type 2 diabetes (<xref ref-type="bibr" rid="bib23">Niu et al., 2008</xref>). In addition, we have demonstrated that ACE2 regulates mitochondrial function in pancreatic β-cells, inhibits hepatic insulin resistance, ameliorates hepatic steatosis, and improves glucose uptake in adipocytes (<xref ref-type="bibr" rid="bib3">Cao et al., 2019</xref>; <xref ref-type="bibr" rid="bib2">Cao et al., 2016</xref>; <xref ref-type="bibr" rid="bib1">Cao et al., 2014</xref>; <xref ref-type="bibr" rid="bib15">Liu et al., 2012a</xref>; <xref ref-type="bibr" rid="bib31">Song et al., 2020</xref>; <xref ref-type="bibr" rid="bib39">Yang et al., 2018</xref>). These findings support the hypothesis that the ACE2-Ang-(1-7)-Mas1 axis may have protective effects on metabolic syndrome.</p><p>In this study, we reported the effects of ACE2 pathway on regulating thermogenesis and energy metabolism via modulating mitochondrial function. We found that <italic>Ace2</italic><sup>-/y</sup> and <italic>Mas1</italic> knockout (<italic>Mas1<sup>-/-</sup></italic>) mice are cold intolerance. We provided compelling genetic, metabolic, physiological, histological, cellular, and molecular evidence to demonstrate that ACE2 pathway is a critical regulator in the maintenance of energy expenditure. This pathway regulates function of brown adipose tissue (BAT) and systemic energy metabolism. Mechanistically, ACE2 pathway activates both Akt/FoxO1 signaling and PKA signaling, leading to induction of uncoupling protein-1 (UCP1) and activation of mitochondrial function. Therefore, ACE2 pathway is a potential treatment target for metabolic disorders including diabetes, obesity, and even cardiovascular diseases.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>Acute cold exposure increases components of ACE2 pathway</title><p>The major tissue of the body where energy is converted into the form of heat to maintain the body temperature is BAT. We found both mRNA level and protein level of <italic>Ace2</italic> and <italic>Mas1</italic> in BAT were obviously higher than the ones in subcutaneous white adipose tissue (scWAT) and epididymal white adipose tissue (eWAT) in mice (<xref ref-type="fig" rid="fig1">Figure 1A and B</xref>). Acute cold exposure caused a significant up-regulation of ACE2 protein expression in BAT (<xref ref-type="fig" rid="fig1">Figure 1C</xref>). Meanwhile, <italic>Ace2</italic> mRNA levels in BAT, scWAT and eWAT, and <italic>Mas1</italic> mRNA levels in BAT and eWAT were increased after exposed to 4 °C for 48 hr (<xref ref-type="fig" rid="fig1">Figure 1D and E</xref>). ACE2 and Ang-(1-7) were also marginally increased in serum upon cold challenge (<xref ref-type="fig" rid="fig1">Figure 1F and G</xref>). These results demonstrated a selective induction of ACE2 pathway in thermogenic adipose depots (BAT and scWAT) in response to cold environment.</p><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>ACE2 pathway is activated by cold exposure.</title><p>Eight-week-old male C57BL/6 J mice were housed at room temperature (RT) for 2 weeks before cold exposure at 4 °C for various time periods as indicated. (<bold>A</bold>) Levels of ACE2 and Mas1 protein from interscapular brown adipose tissue (BAT), subcutaneous and epididymal white adipose tissue (scWAT and eWAT) of C57BL/6 mice at room temperature (RT), as determined by Western blotting (n = 3/each group). (<bold>B</bold>) Levels of <italic>Ace2</italic> and <italic>Mas1</italic> mRNA from BAT, scWAT and eWAT of C57BL/6 mice at RT, as determined by qPCR (n = 3/each group). (<bold>C</bold>) Levels of ACE2 and Mas1 protein from interscapular BAT of C57BL/6 mice at RT or exposed to 4 °C for 6 hr, as determined by western blotting (n = 3/each group). (<bold>D, E</bold>) Levels of <italic>Ace2</italic> and <italic>Mas1</italic> mRNA from BAT, scWAT, eWAT and liver of C57BL/6 mice exposed to 4 °C for 24 hr, as determined by qPCR (n = 6/each group). (<bold>F, G</bold>) Serum levels of ACE2 (<bold>F</bold>) and Ang-(1-7) (<bold>G</bold>), as determined by ELISA (n = 4–6/each group). Data represent mean ± SEM. *p &lt; 0.05, **p &lt; 0.01 and ***p &lt; 0.001 <italic>vs</italic> Control group by Student’s <italic>t-</italic>test, or one-way ANOVA.</p><p><supplementary-material id="fig1sdata1"><label>Figure 1—source data 1.</label><caption><title>Numerical quantification data for <xref ref-type="fig" rid="fig1">Figure 1</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-72266-fig1-data1-v4.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-72266-fig1-v4.tif"/></fig></sec><sec id="s2-2"><title>ACE2 promotes thermogenesis and energy metabolism</title><p>To explore the physiological roles of ACE2 in cold-induced adaptive thermogenesis, we used the HFD-induced <italic>Ace2</italic><sup>-/y</sup> mice. ACE2 is essential for expression of neutral amino acid transporters in the gut (<xref ref-type="bibr" rid="bib12">Hashimoto et al., 2012</xref>). This is consistent with our observation that <italic>Ace2</italic><sup>-/y</sup> mice fed an HFD displayed significantly decreased weight compared to wild-type (WT) mice (<xref ref-type="fig" rid="fig2">Figure 2A</xref>). Serum Ang-(1-7) levels were decreased in the <italic>Ace2</italic><sup>-/y</sup> mice (<xref ref-type="fig" rid="fig2">Figure 2B</xref>). Consistent with previous studies (<xref ref-type="bibr" rid="bib1">Cao et al., 2014</xref>; <xref ref-type="bibr" rid="bib15">Liu et al., 2012a</xref>; <xref ref-type="bibr" rid="bib23">Niu et al., 2008</xref>; <xref ref-type="bibr" rid="bib30">Shi et al., 2018</xref>; <xref ref-type="bibr" rid="bib42">Zhang et al., 2016</xref>), <italic>Ace2</italic><sup>-/y</sup> mice had an impaired glucose tolerance and abnormal lipid profiles (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1A-C</xref>).</p><fig-group><fig id="fig2" position="float"><label>Figure 2.</label><caption><title><italic>Ace2</italic> deficiency impairs thermogenesis, BAT activity, and energy metabolism.</title><p>Eight-week-old male <italic>Ace2<sup>-/y</sup></italic> mice and their wild-type (WT) mice (controls) had a high-fat diet (HFD) for 8 weeks. (<bold>A</bold>) Body weight of <italic>Ace2<sup>-/y</sup></italic> and WT mice fed a HFD for 8 weeks (n = 4–5/each group). (<bold>B</bold>) Serum levels of Ang-(1-7), as determined by ELISA (n = 4–6/each group). (<bold>C–E</bold>) Energy expenditure was evaluated by measurement of oxygen consumption (VO<sub>2</sub>) (<bold>C</bold>), carbon dioxide release (VCO<sub>2</sub>) (<bold>D</bold>) and energy expenditure (EE) (<bold>E</bold>) over a 24 hours period (n = 5/each group). (<bold>F</bold>) Core body temperature at 30 °C, 22°C and 4°C for 8 hr in <italic>Ace2<sup>-/y</sup></italic> and WT mice (n = 5/each group). (<bold>G</bold>) Infrared thermal images at 22 °C in <italic>Ace2<sup>-/y</sup></italic> and WT mice. (<bold>H</bold>) Representative tomography–computed tomography (PET-CT) image and standard uptake values (SUVs) (n = 4/each group). (<bold>I</bold>) Representative haematoxylin and eosin (H&amp;E) staining and uncoupling protein-1 (UCP1) immunostaining from BAT sections of <italic>Ace2<sup>-/y</sup></italic> and WT mice exposure at 4 °C (n = 5/each group). (<bold>J</bold>) Representative western blots showing the changes of key proteins of energy expenditure and thermogenesis in BAT of <italic>Ace2<sup>-/y</sup></italic> and WT mice exposure at 4 °C (n = 3/each group). (<bold>K</bold>) Representative western blots showing the key protein changes in primary brown adipocytes from <italic>Ace2<sup>-/y</sup></italic> and WT mice (n = 3/each group). (<bold>L</bold>) Representative immunofluorescent images of in vitro differentiated primary brown adipocytes of <italic>Ace2<sup>-/y</sup></italic> and WT mice, primary brown adipocytes show staining for UCP1 (red), boron-dipyrromethene (BODIPY) (green; neutral lipid dye), and DAPI (blue; nuclei). (<bold>M</bold>) Continuous measurement of oxygen consumption rate (OCR) in primary brown adipocytes from <italic>Ace2<sup>-/y</sup></italic> mice and WT littermates. Oxygen consumption was performed under basal conditions, following the addition of oligomycin (1 μM), the pharmacological uncoupler FCCP (1 μM) or the Complex III and I inhibitor antimycin A and rotenone (0.5 μM) (n = 4–5/each group). Data represent mean ± SEM. *p &lt; 0.05, **p &lt; 0.01 <italic>vs</italic> WT group by Student’s t-test, or ANCOVA.</p><p><supplementary-material id="fig2sdata1"><label>Figure 2—source data 1.</label><caption><title>Numerical quantification data for <xref ref-type="fig" rid="fig2">Figure 2</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-72266-fig2-data1-v4.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-72266-fig2-v4.tif"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 1.</label><caption><title><italic>Ace2</italic> deficiency impairs adaptative thermogenesis by cold stimulation.</title><p>Eight-week-old male <italic>Ace2<sup>-/y</sup></italic> mice and their WT (control) mice had an HFD for 8 weeks (<italic>Ace2<sup>-/y</sup> vs</italic> WT). (<bold>A–C</bold>) Intraperitoneal glucose tolerance test (IPGTT), serum triglyceride and cholesterol levels in <italic>Ace2<sup>-/y</sup></italic> and WT mice (n = 5–6/each group). (<bold>D–F</bold>) 24 hr food intake, water intake and physical activity were measured in <italic>Ace2<sup>-/y</sup></italic> and WT mice (n = 5/each group). (<bold>G</bold>) Core body temperature at 4 °C for the indicated lengths of time in <italic>Ace2<sup>-/y</sup></italic> and WT mice (n = 4/each group). (<bold>H</bold>) Relative mRNA levels of mitochondrial related genes, fatty acid oxidation related genes and transcription factors in BAT of in <italic>Ace2<sup>-/y</sup></italic> and WT mice exposure at 4 °C (n = 3/each group). (<bold>I</bold>) Relative mRNA levels of mitochondrial related genes, fatty acid oxidation related genes and transcription factors in primary brown adipocytes from <italic>Ace2<sup>-/y</sup></italic> and WT mice (n = 3/each group). Data represent mean ± SEM. *p &lt; 0.05, **p &lt; 0.01 vs WT group by Student’s <italic>t</italic>-test.</p><p><supplementary-material id="fig2s1sdata1"><label>Figure 2—figure supplement 1—source data 1.</label><caption><title>Numerical quantification data for <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-72266-fig2-figsupp1-data1-v4.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-72266-fig2-figsupp1-v4.tif"/></fig></fig-group><p>A key factor for controlling energy homoeostasis is the balance between caloric intake and energy expenditure. Thus, we measured energy expenditure using a comprehensive laboratory animal monitoring system (CLAMS). We observed a decreased oxygen consumption (VO<sub>2</sub>), carbon dioxide release (VCO<sub>2</sub>) and energy expenditure (EE) in <italic>Ace2</italic><sup>-/y</sup> mice (<xref ref-type="fig" rid="fig2">Figure 2C, D and E</xref>), without observable changes in food and/or water intake as well as physical activity, compared to the WT mice (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1D-F</xref>).</p><p>To further examine the differences in energy expenditure among these animals, we performed a cold tolerance test in order to gauge adaptive thermogenesis. <italic>Ace2</italic><sup>-/y</sup> mice had lower thermogenesis than the WT mice in a cold environment (4 °C) (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1G</xref>). To explore the source of thermogenesis, we analyzed the non-shivering thermogenesis (NST) of <italic>Ace2</italic><sup>-/y</sup> mice in thermoneutral condition (30 °C), ambient temperature (22 °C) and acute cold (4 °C) for 8 hr. <italic>Ace2</italic><sup>-/y</sup> mice had lower thermogenesis than the WT mice in either 22 °C or 4 °C (<xref ref-type="fig" rid="fig2">Figure 2F</xref>). This temperature difference was monitored by an infrared camera at 4 °C (<xref ref-type="fig" rid="fig2">Figure 2G</xref>).</p><p>To investigate whether ACE2-induced thermogenesis was related to BAT function, we performed the Positron emission tomography–computed tomography (PET-CT) analysis and the results showed a higher PET-CT signal in BAT of the HFD-induced WT mice than <italic>Ace2</italic><sup>-/y</sup> mice (<xref ref-type="fig" rid="fig2">Figure 2H</xref>). As expected, BAT in <italic>Ace2</italic><sup>-/y</sup> mice displayed larger lipid droplets but reduced multilocular structures compared to the WT mice, and reduced UCP1 expression (<xref ref-type="fig" rid="fig2">Figure 2I</xref>).</p><p>To evaluate the significance of cold-induced ACE2 for thermogenic function of BAT, the expression levels of a network of genes and proteins controlling energy expenditure and thermogenic programming were measured. Protein levels (UCP1, PGC1α, and ATP5A) (<xref ref-type="fig" rid="fig2">Figure 2J</xref>) and mRNA levels (<italic>Ucp1</italic>, <italic>Prmd16,</italic> and <italic>Pparg</italic> (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1H</xref>)) in BAT from <italic>Ace2</italic><sup>-/y</sup> were obviously decreased.</p><p>To validate the above-mentioned change of thermogenesis of BAT was cell autonomous, primary brown adipocytes from <italic>Ace2</italic><sup>-/y</sup> mice was fractionated and differentiated in vitro. Notably, the protein and mRNA expression of known BAT markers were robustly decreased in <italic>Ace2</italic>-deficient primary brown adipocytes (<xref ref-type="fig" rid="fig2">Figure 2K</xref>, <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1I</xref>). Immunohistochemistry was applied to study the level of UCP1 in primary brown adipocytes differentiated from the BAT of the <italic>Ace2</italic><sup>-/y</sup> mice. The result showed the UCP1 expression was reduced in the <italic>Ace2</italic> deficiency primary brown adipocytes (<xref ref-type="fig" rid="fig2">Figure 2L</xref>). More importantly, the oxygen consumption rate (OCR) was significantly decreased in <italic>Ace2</italic>-deficient primary brown adipocytes (<xref ref-type="fig" rid="fig2">Figure 2M</xref>).</p><p>As a complementary approach to the KO mouse models, we carried out gain-of-function studies using <italic>Ace2</italic> over expression in obese diabetic <italic>Lepr<sup>db/db</sup></italic> mice. One week following adenovirus-induced <italic>Ace2</italic> over-expression (Ad-<italic>Ace2</italic>) by tail vein injection in the <italic>Lepr<sup>db/db</sup></italic> mice, both ACE2 (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1A</xref>) in BAT and circulating Ang-(1-7) (<xref ref-type="fig" rid="fig3">Figure 3A</xref>) were increased. Consistent with our previous study, the Ad-<italic>Ace2</italic>-treated mice exhibited an improved metabolic profile as indicated by the significant alleviation of glucose intolerance (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1B</xref>). Notably, although no observable change on the body weight was observed in the two groups (<xref ref-type="fig" rid="fig3">Figure 3B</xref>), serum triglyceride levels decreased in the Ad-<italic>Ace2</italic>-treated mice (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1C</xref>), as well as a minor change in serum cholesterol levels (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1D</xref>).</p><fig-group><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>ACE2 enhances thermogenesis, BAT activity, and energy metabolism in <italic>Lepr<sup>db/db</sup></italic> obese mice.</title><p><italic>Ace2</italic> over-expression adenovirus (Ad-<italic>Ace2</italic>) and Ad-<italic>GFP</italic> (control) were introduced into the <italic>Lepr<sup>db/db</sup></italic> obese mice by tail vein injection. The ad-<italic>Ace2</italic> and Ad-<italic>GFP</italic> treated <italic>Lepr<sup>db/db</sup></italic> mice were used at the 6<sup>th</sup> day post-virus injection. (<bold>A</bold>) Serum levels of Ang-(1-7), as determined by ELISA (n = 6–7/each group). (<bold>B</bold>) Body weight of ad-<italic>Ace2</italic> and Ad-<italic>GFP</italic> treated <italic>Lepr<sup>db/db</sup></italic> mice at the 6<sup>th</sup> day post-virus injection (n = 4–6/each group). (<bold>C–E</bold>) Energy expenditure was evaluated by measurement of oxygen consumption (VO<sub>2</sub>) (<bold>C</bold>), carbon dioxide release (VCO<sub>2</sub>) (<bold>D</bold>) and energy expenditure (EE) (<bold>E</bold>) over a 24-hr period (n = 4–6/each group). (<bold>F</bold>) Core body temperature at 30 °C, 22°C and 4°C for 8 hr (n = 5/each group). (<bold>G</bold>) Infrared thermal images at 22 °C in <italic>Lepr<sup>db/db</sup>+ Ace2</italic> and <italic>Lepr<sup>db/db</sup>+ GFP</italic> mice (n = 4/each group). (<bold>H</bold>) Representative tomography–computed tomography (PET-CT) image and standard uptake values (SUVs) (n = 4/each group). (<bold>I</bold>) Representative H&amp;E staining and UCP1 immunostaining from BAT sections of <italic>Lepr<sup>db/db</sup>+ Ace2</italic> and <italic>Lepr<sup>db/db</sup></italic>+ GFP mice exposure at 4 °C (n = 5/each group). (<bold>J</bold>) Representative western blots showing the changes of key proteins of energy expenditure and thermogenesis in BAT of <italic>Lepr<sup>db/db</sup>+ Ace2</italic> and <italic>Lepr<sup>db/db</sup>+ GFP</italic> mice exposure at 4 °C (n = 3/each group). (<bold>K</bold>) Relative mRNA levels of mitochondrial related genes, fatty acid oxidation related genes and transcription factors in BAT of <italic>Lepr<sup>db/db</sup>+ Ace</italic>2 and <italic>Lepr<sup>db/db</sup>+ GFP</italic> mice exposure at 4 °C (n = 5–6/each group). Data represent mean ± SEM. *p &lt; 0.05, **p &lt; 0.01 <italic>vs</italic> Ad-<italic>GFP</italic> group by Student’s t-test, or ANCOVA.</p><p><supplementary-material id="fig3sdata1"><label>Figure 3—source data 1.</label><caption><title>Numerical quantification data for <xref ref-type="fig" rid="fig3">Figure 3</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-72266-fig3-data1-v4.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-72266-fig3-v4.tif"/></fig><fig id="fig3s1" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 1.</label><caption><title>ACE2 enhance BAT activity and whole-body energy metabolism in <italic>Lepr<sup>db/db</sup></italic> and HFD mice.</title><p>The ad-<italic>Ace2</italic> and Ad-<italic>GFP</italic>-treated <italic>Lepr<sup>db/db</sup></italic> mice were used at the 6th day post-virus injection (<italic>Lepr<sup>db/db</sup></italic>+ Ace2 <italic>vs Lepr<sup>db/db</sup></italic>+ GFP). (<bold>A</bold>) Ace2 overexpression was verified in BAT of Ad-<italic>Ace2</italic>-treated <italic>Lepr<sup>db/db</sup></italic> mice by Western blotting (n = 3/each group). (<bold>B–D</bold>) Intraperitoneal glucose tolerance test (IPGTT), serum triglyceride and cholesterol levels in <italic>Lepr<sup>db/db</sup></italic>+ Ace2 and <italic>Lepr<sup>db/db</sup></italic>+ GFP mice (n = 3–5/each group). (<bold>E–G</bold>) 24 hr food intake, water intake and physical activity were measured in <italic>Lepr<sup>db/db</sup>+ Ace2</italic> and <italic>Lepr<sup>db/db</sup>+ GFP</italic> mice (n = 4–6/each group).(<bold>H, I</bold>) Infrared thermal images at 22 °C and core body temperature at 4 °C for the indicated lengths of time in C57BL/6 and <italic>Lepr<sup>db/d</sup></italic> mice (n = 5/each group). (<bold>J</bold>) Core body temperature at 4 °C for the indicated lengths of time in <italic>Lepr<sup>db/db</sup>+ Ace2</italic> and <italic>Lepr<sup>db/d</sup> + GFP</italic> mice (n = 4–7/each group). (<bold>K</bold>) Core body temperature at 4 °C for the indicated lengths of time in HFD + <italic>Ace2</italic> and HFD + <italic>GFP</italic> mice (n = 6–7/each group). Data represent mean ± SEM. *p &lt; 0.05, **p &lt; 0.01 vs WT/GFP group by Student’s <italic>t</italic>-test.</p><p><supplementary-material id="fig3s1sdata1"><label>Figure 3—figure supplement 1—source data 1.</label><caption><title>Numerical quantification data for <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-72266-fig3-figsupp1-data1-v4.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-72266-fig3-figsupp1-v4.tif"/></fig></fig-group><p>Notably, the Ad-<italic>Ace2</italic>-treated <italic>Lepr<sup>db/db</sup></italic> mice had increased energy expenditure (VO<sub>2</sub>, VCO<sub>2</sub> and EE) (<xref ref-type="fig" rid="fig3">Figure 3C–E</xref>). There was no obvious change in food and/or water intake as well as physical activity (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1E-G</xref>).</p><p>We measured rectal temperature and infrared thermal imaging in the <italic>Lepr<sup>db/db</sup></italic> mice that BAT activity was defective as same as the ones in previous observations (<xref ref-type="bibr" rid="bib37">Trayhurn and Wusteman, 1990</xref>; <xref ref-type="bibr" rid="bib41">Zhang et al., 2014</xref>). The results showed that the thermogenesis of the <italic>Lepr<sup>db/db</sup></italic> mice was severely impaired (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1H, I</xref>). As expected, the Ad-<italic>Ace2</italic> treated <italic>Lepr<sup>db/db</sup></italic> mice and HFD-induced obese mice exhibited better thermogenesis than the control mice in ambient temperature (22 °C) and acute cold (4 °C) conditions (<xref ref-type="fig" rid="fig3">Figure 3F and G</xref>, <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1J,K</xref>). Accordingly, PET-CT result showed that BAT was activated in the Ad-<italic>Ace2</italic>-treated <italic>Lepr<sup>db/db</sup></italic> mice (<xref ref-type="fig" rid="fig3">Figure 3H</xref>). Moreover, BAT in the Ad-<italic>Ace2</italic>-treated <italic>Lepr<sup>db/db</sup></italic> mice had smaller lipid droplets but increased multi-locular structures, and had increased UCP1 expression compared with the control group (<xref ref-type="fig" rid="fig3">Figure 3I</xref>).</p><p>The protein levels of UCP1, ATP5A and UQCRC2 were significantly increased in the BAT from the Ad-<italic>Ace2</italic> treated mice (<xref ref-type="fig" rid="fig3">Figure 3J</xref>). Consistently, the mRNA levels, including <italic>Ucp1</italic>, <italic>ATP synthase F1 subunit beta</italic> (<italic>Atp5b</italic>), <italic>Cox8b</italic>, <italic>Cox7a</italic>, <italic>fatty acid binding protein 4</italic> (<italic>Fabp4</italic>), <italic>Cpt1a</italic>, <italic>Prdm16</italic>, <italic>Ppargc1a</italic> and <italic>Ppargc1b</italic>, were increased in the BAT from the Ad-<italic>Ace2</italic>-treated <italic>Lepr<sup>db/db</sup></italic> mice (<xref ref-type="fig" rid="fig3">Figure 3K</xref>). Taken together, these results indicated that ACE2 effectively regulated the mitochondrial biogenesis and respiratory function in brown adipocytes.</p></sec><sec id="s2-3"><title>Ang-(1-7) promotes thermogenesis and energy metabolism</title><p>To explore the direct physiological roles of Ang-(1-7) in cold-induced adaptive thermogenesis, Ang-(1-7) administration by subcutaneous implantation of micro-osmotic pumps in the <italic>Lepr<sup>db/db</sup></italic> and the HFD-induced obese mice were employed. Serum Ang-(1-7) was increased in Ang-(1-7)-treated mice (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1A</xref>). There are no significant differences in body weight between the Ang-(1-7)-treated <italic>Lepr<sup>db/db</sup></italic> mice and the <italic>Lepr<sup>db/db</sup></italic> control mice (<xref ref-type="fig" rid="fig4">Figure 4A</xref>); however, Ang-(1-7)-treated <italic>Lepr<sup>db/db</sup></italic> mice has an improved glucose tolerance ability (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1B</xref>) and better lipid profiles (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1C, D</xref>). The Ang-(1-7)-treated HFD-induced obese mice displayed a lower body weight compared to the control (<xref ref-type="fig" rid="fig4">Figure 4B</xref>).</p><fig-group><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>Ang-(1-7) promotes thermogenesis, BAT activity, and energy metabolism in the <italic>Lepr<sup>db/db</sup></italic> and the HFD-induced obese mice.</title><p>Ang-(1-7) administration by subcutaneous implanted micro-osmotic pumps in the <italic>Lepr<sup>db/db</sup></italic> obese mice and the high-fat diet (HFD)-induced obese mice were used. The <italic>Lepr<sup>db/db</sup></italic> mice were treated with Ang-(1-7) by subcutaneous infusion of Ang-(1-7) or saline using osmotic mini-pumps for 4 weeks. Six-week-old male C57BL/6 J mice were used to develop obesity by HFD diet for 8 weeks, and the mice treated with Ang-(1-7), A779 (an Ang-(1-7) antagonist), or saline by osmotic mini-pumps at the 4th weeks post-HFD. (<bold>A</bold>) Body weight of <italic>Lepr<sup>db/db</sup></italic>+ Ang-(1-7) and <italic>Lepr<sup>db/db</sup></italic>+ Vehicle mice at the 4th week post micro-osmotic pumps implantation (n = 5–6/each group). (<bold>B</bold>) Body weight of HFD + Ang-(1-7), HFD + A779 and HFD + Vehicle mice at the 4th week post micro-osmotic pumps implantation (n = 4–7/each group). (<bold>C–E</bold>) Energy expenditure was evaluated by measurement of oxygen consumption (VO<sub>2</sub>) (<bold>C</bold>), of carbon dioxide release (VCO<sub>2</sub>) (<bold>D</bold>) and of energy expenditure (EE) (<bold>E</bold>) over a 24 hr period in <italic>Lepr<sup>db/db</sup></italic>+ Ang-(1-7) and <italic>Lepr<sup>db/db</sup></italic>+ Vehicle mice (n = 4–6/each group). (<bold>F</bold>) Core body temperature at 30 °C, 22°C and 4°C for 8 hr in <italic>Lepr<sup>db/db</sup></italic>+ Ang-(1-7) and <italic>Lepr<sup>db/db</sup></italic>-Vehicle mice (n = 5/each group). (<bold>G</bold>) Infrared thermal images at 22 °C in <italic>Lepr<sup>db/db</sup></italic>+ Ang-(1-7) and <italic>Lepr<sup>db/db</sup></italic>+ Vehicle mice. (<bold>H</bold>) Core body temperature at 4 °C for the indicated lengths of time in HFD + Ang-(1-7), HFD + A779 and HFD + Vehicle mice (n = 4–5/each group). (<bold>I</bold>) Representative H&amp;E staining and UCP1 immunostaining from BAT sections of <italic>Lepr<sup>db/db</sup></italic>+ Ang-(1-7) and <italic>Lepr<sup>db/db</sup></italic>+ Vehicle mice exposure at 4 °C (n = 5/each group). (<bold>J</bold>) Representative Positron emission tomography–computed tomography (PET-CT) image and SUVs of <italic>Lepr<sup>db/db</sup></italic>+ Ang-(1-7) and <italic>Lepr<sup>db/db</sup></italic>+ Vehicle mice (n = 4/each group). (<bold>K</bold>) Representative PET-CT image and SUVs of HFD + Ang-(1-7), HFD + A779 and HFD + Vehicle mice (n = 3/each group). (<bold>L</bold>) Representative western blots showing the changes of key proteins of energy expenditure and thermogenesis in BAT of <italic>Lepr<sup>db/db</sup></italic>+ Ang-(1-7) and <italic>Lepr<sup>db/db</sup></italic>+ Vehicle mice exposure at 4 °C (n = 3/each group). (<bold>M</bold>) Representative western blots showing the changes of key proteins of energy expenditure and thermogenesis in BAT of HFD + Ang-(1-7), HFD + A779 and HFD + Vehicle mice exposure at 4 °C (n = 3/each group). Data represent mean ± SEM. *p &lt; 0.05, **p &lt; 0.01 <italic>vs</italic> Vehicle group by Student’s t-test, ANCOVA, or one-way ANOVA.</p><p><supplementary-material id="fig4sdata1"><label>Figure 4—source data 1.</label><caption><title>Numerical quantification data for <xref ref-type="fig" rid="fig4">Figure 4</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-72266-fig4-data1-v4.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-72266-fig4-v4.tif"/></fig><fig id="fig4s1" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 1.</label><caption><title>Ang-(1-7) promoted thermogenesis and energetic metabolism in BAT of <italic>Lepr<sup>db/db</sup></italic> mice during cold challenge.</title><p><italic>Lepr<sup>db/db</sup></italic> mice were treated with Ang-(1-7) by subcutaneous infusion of Ang-(1-7) or saline using osmotic mini-pumps for 4 weeks (<italic>Lepr<sup>db/db</sup></italic>+ Ang-(1-7) <italic>vs Lepr<sup>db/db</sup></italic>+ Vehicle). (<bold>A</bold>) Serum levels of Ang-(1-7) as determined by ELISA in <italic>Lepr<sup>db/db</sup></italic>+ Ang-(1-7) and <italic>Lepr<sup>db/db</sup></italic>+ Vehicle mice (n = 6–8/each group). (<bold>B–D</bold>) Intraperitoneal glucose tolerance test (IPGTT), serum triglyceride and cholesterol levels in <italic>Lepr<sup>db/db</sup></italic>+ Ang-(1-7) and <italic>Lepr<sup>db/db</sup></italic>+ Vehicle mice (n = 4–5/each group). (<bold>E–G</bold>) 24 h food intake, water intake and physical activity were measured in <italic>Lepr<sup>db/db</sup></italic>+ Ang-(1-7) and <italic>Lepr<sup>db/db</sup></italic>+ Vehicle mice (n = 4–6/each group). (<bold>H</bold>) Core body temperature at 4 °C for the indicated lengths of time in <italic>Lepr<sup>db/db</sup></italic>+ Ang-(1-7) and <italic>Lepr<sup>db/db</sup></italic>+ Vehicle mice (n = 5–6/each group). (<bold>I</bold>) Relative mRNA levels of mitochondrial related genes, fatty acid oxidation related genes and transcription factors in BAT of in <italic>Lepr<sup>db/db</sup></italic>+ Ang-(1-7) and <italic>Lepr<sup>db/db</sup></italic>+ Vehicle mice exposure at 4 °C (n = 5–6/each group). Data represent mean ± SEM. *p&lt; 0.05, **p &lt; 0.01 vs Vehicle group by Student’s <italic>t</italic>-test.</p><p><supplementary-material id="fig4s1sdata1"><label>Figure 4—figure supplement 1—source data 1.</label><caption><title>Numerical quantification data for <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-72266-fig4-figsupp1-data1-v4.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-72266-fig4-figsupp1-v4.tif"/></fig></fig-group><p>Notably, the Ang-(1-7) treated <italic>Lepr<sup>db/db</sup></italic> mice had increased energy expenditure (VO<sub>2</sub>, VCO<sub>2</sub>, and EE) (<xref ref-type="fig" rid="fig4">Figure 4C–E</xref>) without any changes in food and/or water intake as well as physical activity (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1E-G</xref>). Moreover, the Ang-(1-7) treated <italic>Lepr<sup>db/db</sup></italic> and the HFD-induced obese mice were better able to defend their body temperature during environmental cold (22 °C) and acute cold stress (4 °C) compared to the control (<xref ref-type="fig" rid="fig4">Figure 4F–H</xref>, <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1H</xref>). Meanwhile, the Ang-(1-7)-treated <italic>Lepr<sup>db/db</sup></italic> mice had increased multi-locular structures but smaller lipid droplets, and increased UCP1 expression comparing to the control group (<xref ref-type="fig" rid="fig4">Figure 4I</xref>). Accordingly, the Ang-(1-7)-treated <italic>Lepr<sup>db/db</sup></italic> and the HFD-induced obese mice showed more <sup>18</sup>F-FDG uptake in the BAT than the control mice recorded by PET-CT (<xref ref-type="fig" rid="fig4">Figure 4J and K</xref>).</p><p>The protein levels of UCP1 and PGC1α were significantly induced in the BAT from the Ang-(1-7) treated <italic>Lepr<sup>db/db</sup></italic> and the HFD-induced obese mice (<xref ref-type="fig" rid="fig4">Figure 4L and M</xref>). The mRNA levels, including <italic>Ucp1</italic>, <italic>Ppargc1a</italic>, <italic>Cidea</italic>, <italic>Atp5b</italic>, <italic>Cox4</italic>, <italic>Cox8b</italic>, <italic>Cox7a, Mcad,</italic> and <italic>Fabp2</italic>, were increased in the BAT from the Ang-(1-7)-treated <italic>Lepr<sup>db/db</sup></italic> mice (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1I</xref>).</p><p>To sum up, our results suggested that the enhanced thermogenesis effect in the Ad-<italic>Ace2</italic> and Ang-(1-7) treated mice is caused by the increment of Ang-(1-7) levels, which demonstrates that Ang-(1-7) is crucial to the maintenance of thermogenesis.</p></sec><sec id="s2-4"><title>Ablation of <italic>Mas1</italic> impairs thermogenesis in brown adipose tissue</title><p>Since the Ang-(1-7), produced by ACE2, realized the function through the Mas1 receptor, these results above prompted us to hypothesize that the Mas1 receptor determines the effect of Ang-(1-7) in brown adipose tissue. Firstly, the HFD-induced <italic>Mas1<sup>-/-</sup></italic>mice (low Ang-(1-7) action model) were used to assess the therapeutic effects (interventional effects) of Mas1 on energy metabolism. Although serum Ang-(1-7) levels were increased, the <italic>Mas1<sup>-/-</sup></italic>mice had an impaired glucose tolerance, abnormal lipid profiles (<xref ref-type="fig" rid="fig5">Figure 5A</xref>, <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1A-C</xref>), and significantly increased body weight compared to the WT mice (<xref ref-type="fig" rid="fig5">Figure 5B</xref>). Meanwhile, the <italic>Mas1<sup>-/-</sup></italic> mice exhibited decreased oxygen consumption (VO<sub>2</sub>) (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1D</xref>) without any changes in food and/or water intake as well as physical activity (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1E-G</xref>). Moreover, the <italic>Mas1<sup>-/-</sup></italic> mice had lower thermogenesis than the WT mice in either 22 °C or 4 °C (<xref ref-type="fig" rid="fig5">Figure 5C, D and F</xref>). PET-CT analysis illustrated that the <italic>Mas1<sup>-/-</sup></italic> mice has less <sup>18</sup>F-FDG uptake in BAT than the WT mice (<xref ref-type="fig" rid="fig5">Figure 5E</xref>). Consistently, the <italic>Mas1<sup>-/-</sup></italic> mice displayed larger lipid droplets and reduced multilocular structures, and had reduced UCP1 expression compared with the WT mice (<xref ref-type="fig" rid="fig5">Figure 5G</xref>). Nevertheless, deletion of <italic>Mas1</italic> resulted in a striking repression of BAT thermogenic protein (UCP-1, UQCRC2, and SDHB) (<xref ref-type="fig" rid="fig5">Figure 5H</xref>) and genes (e.g. <italic>Ucp1</italic>, <italic>Prmd16</italic>, <italic>Ppargc1a</italic>, <italic>Ppargc1b</italic>, <italic>Atp5b</italic>, <italic>Cox7a,</italic> and <italic>Cpt1a</italic>) (<xref ref-type="fig" rid="fig5">Figure 5I</xref>).</p><fig-group><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>Ablation of <italic>Mas1</italic> impairs thermogenesis, BAT activity, and energetic metabolism.</title><p>(<bold>A–I</bold>) Eight-week-old male <italic>Mas1<sup>-/-</sup></italic> mice and their WT (control) mice had a high-fat diet (HFD) for 8 weeks (<italic>Mas1<sup>-/-</sup> vs</italic> WT). (<bold>J–O</bold>) BAT of C57B/L6 recipient mice was removed from the interscapular region. Then, the BAT dissected from <italic>Mas1<sup>-/-</sup></italic> donor mice, was subcutaneously transplanted into the dorsal interscapular region of C57B/L6 recipient mice (WT+ <italic>Mas1<sup>-/-</sup></italic>-BAT). C57B/L6 recipient mice transplanted with C57B/L6 BAT (WT+ WT BAT) and C57B/L6 epididymal white adipose tissue (eWAT) (WT+ WT eWAT) were used as control. The recipient mice were then fed an HFD immediately after the transplantation and continued for 10 weeks (WT+ <italic>Mas1<sup>-/-</sup></italic>-BAT <italic>vs</italic> WT+ WT BAT, WT+ WT eWAT). (<bold>A</bold>) Serum levels of Ang-(1-7) as determined by ELISA in <italic>Mas1<sup>-/-</sup></italic> and WT mice (n = 3–5/each group). (<bold>B</bold>) Body weight in <italic>Mas1<sup>-/-</sup></italic> and WT mice fed an HFD for 8 weeks (n = 4–5/each group). (<bold>C</bold>) Core body temperature at 30 °C, 22°C and 4°C for 8 hr in <italic>Mas1<sup>-/-</sup></italic> and WT mice (n = 5/each group).(<bold>D</bold>) Infrared thermal images at 22 °C in <italic>Mas1<sup>-/-</sup></italic> and WT mice. (<bold>E</bold>) Representative PET-CT image and SUVs of <italic>Mas1<sup>-/-</sup></italic> and WT mice (n = 3/each group). (<bold>F</bold>) Core body temperature at 4 °C for the indicated lengths of time in <italic>Mas1<sup>-/-</sup></italic> and WT mice (n = 4–5/each group). (<bold>G</bold>) Representative H&amp;E staining and UCP1 immunostaining from BAT sections of <italic>Mas1<sup>-/-</sup></italic> and WT mice exposure at 4 °C (n = 5/each group). (<bold>H</bold>) Representative western blots showing the changes of key proteins in BAT of <italic>Mas1<sup>-/-</sup></italic> and WT mice exposure at 4 °C (n = 3/each group). (<bold>I</bold>) Relative mRNA levels of mitochondrial related genes, fatty acid oxidation related genes and transcription factors in BAT of in <italic>Mas1<sup>-/-</sup></italic> and WT mice exposure at 4 °C (n = 5–6/each group). (<bold>J</bold>) Intraperitoneal glucose tolerance test (GTT) and the average area under the curve (AUC) in WT+ <italic>Mas1<sup>-/-</sup></italic>-BAT, WT+ WT BAT and WT+ WT eWAT mice fed an HFD for 8 weeks after transplantation (n = 6–7/each group). (<bold>K</bold>) Insulin tolerance test (ITT) and AUC in WT+ <italic>Mas1<sup>-/-</sup></italic>-BAT, WT+ WT BAT and WT+ WT eWAT mice fed an HFD for 8 weeks after transplantation (n = 5–6/each group). (<bold>L</bold>) Body weight time course in WT+ <italic>Mas1<sup>-/-</sup></italic>-BAT, WT+ WT BAT and WT+ WT eWAT mice fed an HFD over 10 weeks after transplantation (n = 10/each group). (<bold>M–O</bold>) Energy expenditure was evaluated by measurement of oxygen consumption (VO<sub>2</sub>) (<bold>M</bold>), of carbon dioxide release (VCO<sub>2</sub>) (<bold>N</bold>) and of energy expenditure (EE) (<bold>O</bold>) over a 24 hr period in WT+ <italic>Mas1<sup>-/-</sup></italic>-BAT, WT+ WT BAT and WT+ WT eWAT mice (n = 5/each group). Data represent mean ± SEM. *p &lt; 0.05, **p &lt; 0.01 <italic>vs</italic> WT/WT-BAT group by Student’s t-test, ANCOVA, or one-way ANOVA.</p><p><supplementary-material id="fig5sdata1"><label>Figure 5—source data 1.</label><caption><title>Numerical quantification data for <xref ref-type="fig" rid="fig5">Figure 5</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-72266-fig5-data1-v4.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-72266-fig5-v4.tif"/></fig><fig id="fig5s1" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 1.</label><caption><title>Ablation of <italic>Mas1</italic> impairs thermogenesis, BAT activity, and energetic metabolism.</title><p>(<bold>A–C</bold>) Eight-week-old male <italic>Mas1<sup>-/-</sup></italic> mice and their WT (control) mice had a high-fat diet (HFD) for 8 weeks (<italic>Mas1<sup>-/-</sup> vs</italic> WT). (<bold>D–F</bold>) BAT of C57B/L6 recipient mice was removed from the interscapular region. Then, the BAT dissected from <italic>Mas1<sup>-/-</sup></italic> donor mice, was subcutaneously transplanted into the dorsal interscapular region of C57B/L6 recipient mice (WT+ <italic>Mas1<sup>-/-</sup></italic>-BAT). C57B/L6 recipient mice transplanted with C57B/L6 BAT (WT+ WT BAT) and C57B/L6 epididymal white adipose tissue (eWAT) (WT+ WT eWAT) were used as control. The recipient mice were then fed an HFD immediately after the transplantation and continued for 10 weeks (WT+ <italic>Mas1<sup>-/-</sup></italic>-BAT <italic>vs</italic> WT+ WT BAT, WT+ WT eWAT). (<bold>A–C</bold>) Intraperitoneal glucose tolerance test (IPGTT), serum triglyceride and cholesterol levels in <italic>Mas1<sup>-/-</sup></italic> and WT mice (n = 5–10/each group). (<bold>D</bold>) Energy expenditure was evaluated by measurement of oxygen consumption (VO<sub>2</sub>) over a 24 hr period in <italic>Mas1<sup>-/-</sup></italic> and WT mice (n = 5/each group). (<bold>E–G</bold>) 24 hr food intake, water intake and physical activity were measured in <italic>Mas1<sup>-/-</sup></italic> and WT mice (n = 5/each group). (<bold>H–J</bold>) 24 hr food intake, water intake and physical activity were measured in WT+ <italic>Mas1<sup>-/-</sup></italic>-BAT, WT+ WT BAT and WT+ WT eWAT mice fed an HFD for 8 weeks after transplantation (n = 4/each group). Data represent mean ± SEM. *p &lt; 0.05, **p &lt; 0.01 <italic>vs</italic> WT/WT-BAT group by Student’s <italic>t</italic>-test, or one-way ANOVA.</p><p><supplementary-material id="fig5s1sdata1"><label>Figure 5—figure supplement 1—source data 1.</label><caption><title>Numerical quantification data for <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-72266-fig5-figsupp1-data1-v4.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-72266-fig5-figsupp1-v4.tif"/></fig></fig-group><p>To investigate the role of the Mas1 receptor in BAT, we generated BAT-specific <italic>Mas1</italic> knockout mice (<italic>Mas1<sup>-/-</sup></italic> BAT transplanted mice). According to the previous studies (<xref ref-type="bibr" rid="bib17">Liu et al., 2013</xref>; <xref ref-type="bibr" rid="bib40">Yuan et al., 2016</xref>), firstly, BAT of the C57B/L6 recipient mice was removed from the interscapular region. Then, the BAT, which dissected from strain-, sex-, and age-matched <italic>Mas1<sup>-/-</sup></italic> donor mice, was subcutaneously transplanted into the dorsal interscapular region of the C57B/L6 recipient mice (WT + <italic>Mas1<sup>-/-</sup></italic>-BAT). As controls, C57B/L6-recipient mice transplanted with C57B/L6 BAT (WT + WT BAT) and C57B/L6 epididymal white adipose tissue (eWAT) (WT + WT eWAT) were used as positive control and negative control, respectively. After the transplantation, the recipient mice were fed by HFD for 10 weeks.</p><p>Interestingly, compared with the WT + WT BAT control mice, the WT + <italic>Mas1<sup>-/-</sup></italic>-BAT mice showed greatly impaired HFD-induced insulin resistance. There is no significant difference between the WT + <italic>Mas1<sup>-/-</sup></italic>-BAT mice and the WT + WT eWAT mice in intraperitoneal glucose tolerance test (GTT) and the insulin tolerance test (ITT) (<xref ref-type="fig" rid="fig5">Figure 5J and K</xref>). Notably, <italic>Mas1<sup>-/-</sup></italic>BAT transplantation also strikingly induced HFD-induced weight gain in the WT + <italic>Mas1<sup>-/-</sup></italic>-BAT mice compared with the WT + WT BAT control mice (<xref ref-type="fig" rid="fig5">Figure 5L</xref>).</p><p>More importantly, compared to the WT + WT BAT control mice, the WT + <italic>Mas1<sup>-/-</sup></italic>-BAT mice had decreased oxygen consumption (VO<sub>2</sub>), carbon dioxide release (VCO<sub>2</sub>), and energy expenditure (EE) (<xref ref-type="fig" rid="fig5">Figure 5M–O</xref>), along with normal food and/or water intake as well as physical activity (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1H-J</xref>). Taken together, these results demonstrate that the Mas1 receptor can directly induce thermogenic program in brown adipose tissues.</p></sec><sec id="s2-5"><title>ACE2 pathway induces white fat browning and thermogenesis</title><p>Next, we investigated the impact of ACE2/Ang-(1-7) on the process of browning of WAT, a prominent feature in subcutaneous white adipose tissue (scWAT). Histological examination of scWAT from the Ad-<italic>Ace2</italic>-treated <italic>Lepr<sup>db/db</sup></italic> obese mice showed a profound morphological transformation toward a BAT-like phenotype (smaller adipocytes with multiple lipid droplets) compared with the control (<xref ref-type="fig" rid="fig6">Figure 6A</xref>). Meanwhile, markers of brown adipocytes, such as <italic>Ucp1</italic>, were significantly increased in scWAT of the Ad-<italic>Ace2</italic>-treated <italic>Lepr<sup>db/db</sup></italic> mice. A much greater induction of transcription factors, including <italic>Prmd16</italic>, <italic>Ppargc1a</italic> and <italic>Ppargc1b</italic>, occurred in the scWAT of the Ad-<italic>Ace2</italic>-treated group (<xref ref-type="fig" rid="fig6">Figure 6B</xref>). As expected, the Ang-(1-7) treated <italic>Lepr<sup>db/db</sup></italic> mice had a similar browning effect as the Ad-<italic>Ace2</italic>-treated <italic>Lepr<sup>db/db</sup></italic> mice in scWAT. Morphological brown-like adipocyte and thermogenic gene expression levels slight increasement were observed in the scWAT after Ang-(1-7) treatment (<xref ref-type="fig" rid="fig6">Figure 6C and D</xref>).</p><fig id="fig6" position="float"><label>Figure 6.</label><caption><title>ACE2 pathway induced white adipose tissue browning in the <italic>Lepr<sup>db/db</sup></italic> obese mice.</title><p>(<bold>A</bold>) Representative H&amp;E staining from subcutaneous white adipose tissue (scWAT) sections of <italic>Lepr<sup>db/db</sup>+ Ace2</italic> and <italic>Lepr<sup>db/db</sup>+ GFP</italic> mice exposure at 4 °C (n = 6–7/each group). (<bold>B</bold>) Relative mRNA levels of mitochondrial related genes, fatty acid oxidation related genes and transcription factors in scWAT of <italic>Lepr<sup>db/db</sup>+ Ace2</italic> and <italic>Lepr<sup>db/db</sup>+ GFP</italic> mice exposure at 4 °C (n = 3–5/each group). (<bold>C</bold>) Representative H&amp;E staining from scWAT sections of <italic>Lepr<sup>db/db</sup></italic>+ Ang-(1-7) and Leprdb/db + Vehicle mice exposure at 4 °C (n = 6–7/each group). (<bold>D</bold>) Relative mRNA levels of mitochondrial related genes, fatty acid oxidation related genes and transcription factors in scWAT of <italic>Lepr<sup>db/db</sup></italic>+ Ang-(1-7) and <italic>Lepr<sup>db/db</sup></italic>+ Vehicle mice exposure at 4 °C (n = 4/each group). (<bold>E</bold>) Representative H&amp;E staining from epididymal white adipose tissue (eWAT) sections of <italic>Lepr<sup>db/db</sup>+ Ace2</italic> and <italic>Lepr<sup>db/db</sup>+ GFP</italic> mice exposure at 4 °C (n = 6–7/each group). (<bold>F</bold>) Relative mRNA levels of mitochondrial related genes, fatty acid oxidation related genes, and transcription factors in eWAT of <italic>Lepr<sup>db/db</sup>+ Ace2</italic> and <italic>Lepr<sup>db/db</sup>+ GFP</italic> mice exposure at 4 °C (n = 4/each group). Data represent mean ± SEM. *p &lt; 0.05, **p &lt; 0.01 vs GFP/Vehicle group by Student’s <italic>t</italic>-test.</p><p><supplementary-material id="fig6sdata1"><label>Figure 6—source data 1.</label><caption><title>Numerical quantification data for <xref ref-type="fig" rid="fig6">Figure 6</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-72266-fig6-data1-v4.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-72266-fig6-v4.tif"/></fig><p>These alterations were restricted to scWAT, but not to epididymal white adipose tissue (eWAT). As shown in <xref ref-type="fig" rid="fig6">Figure 6E</xref>, the morphology and size of eWAT in the Ad-<italic>Ace2</italic>-treated <italic>Lepr<sup>db/db</sup></italic> mice are same compared to the control (<xref ref-type="fig" rid="fig6">Figure 6E</xref>). Meanwhile, no significant increase in the thermogenic gene expression levels in the eWAT of the Ad-<italic>Ace2</italic>-treated <italic>Lepr<sup>db/db</sup></italic> mice was found (<xref ref-type="fig" rid="fig6">Figure 6F</xref>).</p></sec><sec id="s2-6"><title>ACE2 pathway enhances thermogenesis via Akt and PKA signaling</title><p>We further investigated the molecular mechanisms through which ACE2 pathway regulates BAT. Firstly, we performed RNA-seq analysis on BAT isolated from the WT and the <italic>Ace2</italic> KO mice. Notable differences between the two are displayed as 3D-PCA analysis and heat map (<xref ref-type="fig" rid="fig7s1">Figure 7—figure supplement 1A, B</xref>). Consistent with the RT-PCR results of BAT in the <italic>Ace2</italic> KO mice, genetic deficiency of <italic>Ace2</italic> significantly altered expression of genes involved in fatty acid biosynthesis, lipid catabolism, lipid biosynthesis, fatty acid beta-oxidation, and cholesterol biosynthesis in the BAT of the <italic>Ace2</italic> KO mice (<xref ref-type="fig" rid="fig7s1">Figure 7—figure supplement 1C</xref>).</p><p>Interestingly, we found that the expression level of Akt associated genes were significantly decreased in the <italic>Ace2</italic> KO mice compared with the WT mice (<xref ref-type="fig" rid="fig7s1">Figure 7—figure supplement 1D</xref>). The phosphorylation levels of Akt at residues Thr308 was significantly inhibited in BAT of the <italic>Ace2</italic> KO mice (<xref ref-type="fig" rid="fig7">Figure 7A</xref>). Furthermore, the phosphorylation levels of Akt were dramatically increased in BAT of the Ad-<italic>Ace2</italic>-treated mice (<xref ref-type="fig" rid="fig7">Figure 7B</xref>).</p><fig-group><fig id="fig7" position="float"><label>Figure 7.</label><caption><title>ACE2 pathway induces a thermogenesis program through the Akt signaling and the PKA signaling.</title><p>Primary brown adipocytes were isolated, cultured, and treated with Ang-(1-7) (10<sup>–6</sup> M) for 24 hr, Akt inhibitor MK2206 (20 μM) for 24 hr, PKA inhibitor H89 (30 μM) for 24 hr, or adenylylcyclase inhibitor SQ-22536 (10 μM) for 24 hours. (<bold>A, B</bold>) Representative western blots showing the changes of p-Akt308 and Akt in BAT of <italic>Ace2<sup>-/y</sup></italic> (<bold>A</bold>) and <italic>Lepr<sup>db/db</sup></italic>+ Ace2 mice (<bold>B</bold>) exposure at 4 °C (n = 3/each group). (<bold>C</bold>) Representative western blots showing the Akt, UCP1 and forkhead box protein O 1 (FoxO1) Changes (n = 3/each group). (<bold>D</bold>) Relative mRNA levels of thermogenic and mitochondrial genes (n = 4–6/each group). (<bold>E</bold>) Continuous measurement of oxygen consumption rate (OCR) in Ang-(1-7) and MK2206 treated primary brown adipocytes. Oxygen consumption was performed under basal conditions, following the addition of oligomycin (1 μM), the pharmacological uncoupler FCCP (1 μM) or the Complex III and I inhibitor antimycin A and rotenone (0.5 μM) (n = 3–4/each group). (<bold>F, G</bold>) Representative western blots showing the p-PKA and PKA changes in BAT of <italic>Ace2<sup>-/y</sup></italic> (<bold>F</bold>) and <italic>Lepr<sup>db/db</sup>+ Ace2</italic> mice (<bold>G</bold>) exposure at 4 °C (n = 3/each group). (<bold>H</bold>) Relative mRNA levels of thermogenic and mitochondrial genes (n = 4–6/each group). (<bold>I</bold>) Representative western blots showing the UCP1 and PGC1α changes (n = 3/each group). (<bold>J</bold>) Continuous measurement of OCR in Ang-(1-7) and H89-treated primary brown Adipocytes (n = 3–5/each group). Data represent mean ± SEM. *p&lt; 0.05, **p &lt; 0.01 <italic>vs</italic> GFP/WT group by Student’s <italic>t</italic>-test. *p &lt; 0.05, **p &lt; 0.01 vs control group, # p &lt; 0.05, ## p &lt; 0.01 vs Ang-(1-7) group by one-way ANOVA. (<bold>K</bold>) Mechanisms involved in ACE2 pathway activation-induced improvement of BAT function.</p><p><supplementary-material id="fig7sdata1"><label>Figure 7—source data 1.</label><caption><title>Numerical quantification data for <xref ref-type="fig" rid="fig7">Figure 7</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-72266-fig7-data1-v4.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-72266-fig7-v4.tif"/></fig><fig id="fig7s1" position="float" specific-use="child-fig"><label>Figure 7—figure supplement 1.</label><caption><title>RNA-Seq analysis of primary brown adipocytes from <italic>Ace2<sup>-/y</sup></italic> and WT mice.</title><p>(<bold>A</bold>) 3D-PCA analysis represent the deviation of 4 replication within <italic>Ace2<sup>-/y</sup></italic> (Ace2 1–4) and WT mice (WT_BS 1–4). (<bold>B</bold>) Heat map representation of the differentially expressed genes in <italic>Ace2<sup>-/y</sup></italic> and WT mice. Gene expression is coded in color scale (−2–2). Red or green indicates expression levels above or below the median, respectively. The magnitude of deviation from the median is represented by color saturation. (<bold>C</bold>) Heat map of selected genes associated with fatty acid biosynthetic, lipid catabolic, lipid biosynthetic, fatty acid beta-oxidation, and cholesterol biosynthetic, which derived from GO analysis results. (<bold>D</bold>) Table for the expression of Akt signal pathways related genes.</p><p><supplementary-material id="fig7s1sdata1"><label>Figure 7—figure supplement 1—source data 1.</label><caption><title>Numerical quantification data for <xref ref-type="fig" rid="fig7s1">Figure 7—figure supplement 1</xref>.</title></caption><media mime-subtype="xls" mimetype="application" xlink:href="elife-72266-fig7-figsupp1-data1-v4.xls"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-72266-fig7-figsupp1-v4.tif"/></fig><fig id="fig7s2" position="float" specific-use="child-fig"><label>Figure 7—figure supplement 2.</label><caption><title>Ang-(1-7)/ACE2 regulate thermogenesis through Akt and PKA signaling in BAT.</title><p>Primary brown adipocytes were isolated, cultured, infected with Ace2 adenovirus, treated with Ang-(1-7) (10<sup>–6</sup> M) for 24 hr, Akt inhibitor MK2206 (20 μM) for 24 hr, PKA inhibitor H89 (30μ M) for 24 hr, or A779 (10<sup>–5</sup> M) for 24 hr. (<bold>A</bold>) Representative western blots showing the Akt, UCP1, and FoxO1 changes in primary brown adipocytes overexpressing <italic>Ace2</italic> at day 7 and treated with MK2206 (n = 3/each group). (<bold>B</bold>) Relative mRNA levels of thermogenic and mitochondrial genes. n = 3/each group. (<bold>C</bold>) Continuous measurement of OCR in primary brown adipocytes overexpressing <italic>Ace2</italic> and treated with MK2206. Oxygen consumption was performed under basal conditions, following the addition of oligomycin (1 μM), the pharmacological uncoupler FCCP (1 μM) or the Complex III and I inhibitor antimycin A and rotenone (0.5 μM) (n = 3–9/each group). (<bold>D</bold>) Representative western blots showing the p-PKA and PKA changes in BAT of <italic>Mas1</italic><sup>-/-</sup> mice exposure at 4 °C (n = 3/each group). (<bold>E</bold>) Representative western blots showing the p-PKA and PKA changes in Ang-(1-7) and H89-treated primary brown adipocytes (n = 3/each group). (<bold>F</bold>) Continuous measurement of OCR in primary brown adipocytes overexpressing <italic>Ace2</italic> and treated with H89 (n = 3–9/each group). (<bold>G</bold>) Continuous measurement of OCR in primary brown adipocytes overexpressing <italic>Ace2</italic> and treated with H89, MK2206, and H89+ MK2206 (n = 3–9/each group). (<bold>H</bold>) Continuous measurement of OCR in Ang-(1-7), Ang-(1-7)+ H89, Ang-(1-7)+ MK2206, and Ang-(1-7)+ A779 treated primary brown adipocytes (n = 3–15/each group). Data represent mean ± SEM. *p &lt; 0.05, **p &lt; 0.01 vs WT group by Student’s <italic>t</italic>-test. *p &lt; 0.05, **p &lt; 0.01 vs control group, # p &lt; 0.05, ## p &lt; 0.01 vs Ace2/Ang-(1-7) group by one-way ANOVA.</p><p><supplementary-material id="fig7s2sdata1"><label>Figure 7—figure supplement 2—source data 1.</label><caption><title>Numerical quantification data for <xref ref-type="fig" rid="fig7s2">Figure 7—figure supplement 2</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-72266-fig7-figsupp2-data1-v4.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-72266-fig7-figsupp2-v4.tif"/></fig></fig-group><p>These results prompted us to consider whether ACE2 pathway regulates the function of BAT via Akt signaling. Thus, we treated primary brown adipocytes which isolated from mice with Ang-(1-7). We found phosphorylation of Akt was activated by Ang-(1-7), accompanied by UCP1 up-regulation and forkhead box-containing protein O subfamily-1 (FoxO1) phosphorylation (<xref ref-type="fig" rid="fig7">Figure 7C</xref>). MK2206, an Akt inhibitor (<xref ref-type="bibr" rid="bib5">Chorner and Moorehead, 2018</xref>; <xref ref-type="bibr" rid="bib19">Matsuzaki et al., 2018</xref>), suppressed Ang-(1-7)-induced UCP1 up-regulation and FoxO1 phosphorylation (<xref ref-type="fig" rid="fig7">Figure 7C</xref>). Compared to Ang-(1-7)-treated primary brown adipocytes cells, MK2206 down-regulated the mRNA levels of <italic>Ucp1</italic>, <italic>Ppargc1a</italic>, <italic>Cidea</italic>, <italic>Atp5b</italic>, <italic>Fabp4,</italic> and <italic>Cpt1a</italic> genes (<xref ref-type="fig" rid="fig7">Figure 7D</xref>). More importantly, Ang-(1-7)-treated primary brown adipocytes exhibited higher OCR, and MK2206 inhibited OCR in the Ang-(1-7) treated primary brown adipocytes (<xref ref-type="fig" rid="fig7">Figure 7E</xref>). Accordingly, the <italic>Ace2</italic>-overexpressing primary brown adipocytes cells showed a similar result. MK2206 suppressed ACE2 induced up-regulation of protein (UCP1 and phosphorylated FoxO1) (<xref ref-type="fig" rid="fig7s2">Figure 7—figure supplement 2A</xref>) and mRNA (<italic>Ucp1</italic> and <italic>Cpt1a</italic>) (<xref ref-type="fig" rid="fig7s2">Figure 7—figure supplement 2B</xref>), as well as action on OCR (<xref ref-type="fig" rid="fig7s2">Figure 7—figure supplement 2C</xref>). These results suggest that the Akt signaling are required for the thermogenic activity of ACE2 pathway.</p><p>After the determination that ACE2 pathway regulates adaptive thermogenesis through the Akt signaling, we paid attention on whether this program could still be provoked by protein kinase A (PKA) signaling, a pathway known to be involved in the canonical thermogenic activation of fat cells. Interestingly, we found that the phosphorylation level of PKA was significantly inhibited in BAT of the <italic>Ace2</italic> KO mice (<xref ref-type="fig" rid="fig7">Figure 7F</xref>). Similar results appeared in the <italic>Mas1</italic> KO mice (<xref ref-type="fig" rid="fig7s2">Figure 7—figure supplement 2D</xref>). However, the phosphorylation level of PKA was increased in BAT of the Ad-<italic>Ace2</italic>-treated <italic>Lepr<sup>db/db</sup></italic> mice (<xref ref-type="fig" rid="fig7">Figure 7G</xref>).</p><p>To further elucidate the study on the mechanism of Ang-(1-7)-induced PKA signaling, we administrated Ang-(1-7)-treated primary brown adipocytes with PKA and adenylylcyclase inhibitors, simultaneously. Firstly, the Ang-(1-7)-induced PKA signaling was validated in primary brown adipocytes (<xref ref-type="fig" rid="fig7s2">Figure 7—figure supplement 2E</xref>). However, H89, a PKA inhibitor, significantly blunted the Ang-(1-7)-induced mRNA levels (<italic>Ucp1</italic>, <italic>Cidea,</italic> and <italic>Fabp4</italic>) (<xref ref-type="fig" rid="fig7">Figure 7H</xref>) and protein levels (UCP1 and PGC1α) (<xref ref-type="fig" rid="fig7">Figure 7I</xref>). Similar effects were observed by using SQ-22536, an adenylylcyclase inhibitor on the formation of intracellular cAMP (<xref ref-type="fig" rid="fig7">Figure 7H,I</xref>). As expected, the Ang-(1-7)-treated primary brown adipocytes exhibited higher OCR, and H89 inhibited OCR in the Ang-(1-7)-treated primary brown adipocytes (<xref ref-type="fig" rid="fig7">Figure 7J</xref>). H89 also suppressed ACE2-induced maximal respiration (<xref ref-type="fig" rid="fig7s2">Figure 7—figure supplement 2F</xref>). Our results thus strongly suggest that the PKA signaling is important for the thermogenic activity of ACE2 pathway.</p><p>Combine with the above result, these data indicated that Ang-(1-7) treatment induced respiration at least partly through Akt and PKA signaling pathway. Notably, treatment with PKA inhibitors on non-Ang-(1-7) stimulated cells results in very little change in OCR, whereas treatment on Ang-(1-7) stimulated cells results in reversion to normal OCR levels (<xref ref-type="fig" rid="fig7">Figure 7J</xref>). In contrast, treatment of non-Ang-(1-7) stimulated cells with AKT inhibitors led to an equivalent level of decrease in OCR as in Ang-(1-7)-treated cells (<xref ref-type="fig" rid="fig7">Figure 7E</xref>), suggesting that AKT inhibition may generically decrease OCR in adipocytes, whereas inhibiting PKA only affects the OCR of Ang-(1-7)-treated cells. PKA is more likely responsible in the changes in mitochondrial activity due to Ang-(1-7) stimulation than AKT signaling. More importantly, our data showed that co-treatment with Akt and PKA inhibitors have an additive effect in <italic>Ace2</italic>-overexpressing primary brown adipocytes cells (<xref ref-type="fig" rid="fig7s2">Figure 7—figure supplement 2G</xref>).</p><p>Furthermore, in Ang-(1-7)-treated primary brown adipocytes, there is no significant difference between A779 and PKA/Akt inhibitor treatment on OCR (<xref ref-type="fig" rid="fig7s2">Figure 7—figure supplement 2H</xref>). This data indicated that A779 treatment plays similar effect to PKA/Akt inhibitor on mitochondrial respiration in Ang-(1-7) treated cells.</p></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>RAS is classically known to regulate blood pressure and maintain water and electrolyte balance. It also plays as a crucial role in metabolic disorders, such as obesity and insulin resistance (<xref ref-type="bibr" rid="bib7">Das, 2016</xref>). Comprehensive understanding of the complexly biological function of the RAS remains a major biomedical challenge. Recently, a research group separately reported that ACE2 and Ang-(1-7) exert anti-obesity effect by BAT in HFD-induced obesity mice (<xref ref-type="bibr" rid="bib13">Kawabe et al., 2019</xref>; <xref ref-type="bibr" rid="bib21">Morimoto et al., 2018</xref>). In ACE2 pathway, ACE2, Ang-(1-7), and Mas1 receptor interact and antagonize each other’s actions. As these two studies only used gain-of-function approaches, they cannot clarify the specific physiological role of ACE2-Ang1-7-Mas1 axis in the thermogenesis brown adipose tissue. Therefore, it is critically important and urgent to systematically analyze the function of these three elements using reverse genetics approaches.</p><p>In our study, we used seven mice models, <italic>Ace2</italic> KO mice, Ad-<italic>Ace2 Lepr<sup>db/db</sup></italic> and HFD mice, Ang-(1-7) treated <italic>Lepr<sup>db/db</sup></italic> and HFD mice, <italic>Mas1</italic> KO mice and BAT-specific <italic>Mas1</italic> knockout mice (<italic>Mas1<sup>-/-</sup></italic> BAT transplanted mice), respectively. Based on a series of functional assays in these mouse models and primary brown adipocytes, we effectively confirmed that the ACE2 pathway regulates glucose and lipid homeostasis. Furthermore, ACE2 pathway maintains thermogenesis and systemic energy metabolism. Molecular analyses, including the use of several inhibitors of Akt and PKA, demonstrate that the effects of ACE2 pathway on brown adipocytes are mediated by both the Akt signaling and the PKA signaling, resulting in the activation of PGC1α, followed by activation of UCP1 (<xref ref-type="fig" rid="fig7">Figure 7K</xref>). These findings significantly expand our understanding of the biological function of RAS. Furthermore, our results propose a new concept that the ACE2 pathway can improve obesity and the associated metabolic disorders.</p><p>BAT, which utilizes glucose and fatty acids for thermogenesis, contains large number of mitochondria and promotes thermogenesis by mitochondrial respiration through UCP1. BAT-specific UCP1, localized in the inner mitochondrial membrane, plays a fundamental role in thermogenesis. In response to stimulation, activation of PGC1α up-regulates the expression of BAT-specific UCP1, which dissipates the proton motive force across the inner mitochondrial membranes, and consequentially producing ATP (<xref ref-type="bibr" rid="bib27">Sambeat et al., 2016</xref>; <xref ref-type="bibr" rid="bib29">Schreiber et al., 2017</xref>). On the other hand, PGC1α induces the acquisition of BAT features, including the expression of mitochondria and fatty acid-oxidation and thermogenic genes (<xref ref-type="bibr" rid="bib25">Puigserver et al., 1998</xref>; <xref ref-type="bibr" rid="bib35">Tiraby et al., 2003</xref>). We found that the mRNA levels of <italic>Ucp1</italic>, <italic>Ppargc1a</italic>, mitochondrial program and fatty acid oxidation related genes (<italic>Ppargc1b</italic>, <italic>Atp5b</italic>, <italic>Cox7a</italic>, <italic>Cox8b</italic>, <italic>Fabp4,</italic> and <italic>Cpt1a</italic>) were up-regulated in the <italic>Ace2</italic> overexpression and the Ang-(1-7)-treated <italic>Lepr<sup>db/db</sup></italic> mice, whereas down-regulated in the <italic>Ace2</italic> KO or the <italic>Mas1</italic> KO mice. These results supported that PGC1α and <italic>UCP1</italic> might be critical for the effects of ACE2 pathway on thermogenesis.</p><p>We also investigated the underlying mechanisms of ACE2 pathway on the regulation of BAT via the Akt signaling and the PKA signaling (<xref ref-type="fig" rid="fig7">Figure 7K</xref>).</p><p>First, we verified the Akt signaling in the downstream of ACE2 pathway. Akt has a critical function in cell survival and energy balance. Multiple pieces of evidence show that activation of PI3K is followed by the activation of Akt, which in turn triggers a complex cascade of events that include the inhibition of FoxO1 transcription factors and thus the activation of <italic>Ucp1</italic> and its transcriptional regulator PGC1α (<xref ref-type="bibr" rid="bib22">Nakae et al., 2008</xref>; <xref ref-type="bibr" rid="bib24">Ortega-Molina et al., 2012</xref>). In human and 3T3-L1 preadipocytes, Ang-(1-7)-Mas1 signaling promotes adipogenesis via activation of PI3K-Akt signaling (<xref ref-type="bibr" rid="bib33">Than et al., 2013</xref>). AT2R activation induces white adipocyte browning by increasing PPARγ expression, at least in part, via PI3K-Akt signaling pathways (<xref ref-type="bibr" rid="bib34">Than et al., 2017</xref>). We previously reported that ACE2 and Ang-(1-7) can activate Akt signaling to ameliorate hepatic steatosis (<xref ref-type="bibr" rid="bib2">Cao et al., 2016</xref>; <xref ref-type="bibr" rid="bib1">Cao et al., 2014</xref>). In the present study, the <italic>Ace2</italic> KO and the <italic>Mas1</italic> KO mice displayed a strong decrease in Akt S308 phosphorylation in BAT. The <italic>Ace2</italic> over-expression or the Ang-(1-7) treatment activated Akt S308 phosphorylation in BAT. Furthermore, the effect of ACE2-Ang-(1-7) on primary brown adipocytes can be attenuated by Akt inhibitor. These results suggest that the Akt signaling might also play a role in ACE2 pathway related regulation of BAT function.</p><p>Second, we verified the PKA signaling in the downstream of ACE2 pathway. The Mas1 receptor was shown to constitutively couple to Gαs, including Gαi, Gαq, and Gα12/13proteins (<xref ref-type="bibr" rid="bib8">Dias-Peixoto et al., 2008</xref>; <xref ref-type="bibr" rid="bib11">Gomes et al., 2012</xref>; <xref ref-type="bibr" rid="bib36">Tirupula et al., 2014</xref>). In the kidney, Ang-(1-7) treatment increased cAMP levels and activated PKA through Gαs activation by the Mas1 receptor (<xref ref-type="bibr" rid="bib16">Liu et al., 2012b</xref>; <xref ref-type="bibr" rid="bib18">Magaldi et al., 2003</xref>). Ang-(1-7) regulates insulin secretion through a Mas1-dependent cAMP signaling pathway (<xref ref-type="bibr" rid="bib26">Sahr et al., 2016</xref>). It is well known that norepinephrine released from the sympathetic nerves is a powerful stimulator of BAT. Norepinephrine activates BAT thermogenic program via PKA signaling, followed by the UCP1-mediated proton uncoupling (<xref ref-type="bibr" rid="bib32">Su et al., 2017</xref>). In this study, the PKA signaling in BAT was changed significantly by ACE2 pathway in mice model. In addition, the effect of ACE2 pathway on primary brown adipocytes can be depressed by cAMP and PKA inhibitor.</p><p>Previously, we demonstrate that the ACE2 pathway is involved in the regulation of glucose and lipid homeostasis with limited understanding of the underlying mechanisms (<xref ref-type="bibr" rid="bib1">Cao et al., 2014</xref>; <xref ref-type="bibr" rid="bib15">Liu et al., 2012a</xref>; <xref ref-type="bibr" rid="bib23">Niu et al., 2008</xref>; <xref ref-type="bibr" rid="bib30">Shi et al., 2018</xref>; <xref ref-type="bibr" rid="bib42">Zhang et al., 2016</xref>). Here, for the first time, we provide evidence that the alteration in glucose and lipid homeostasis is associated with the change in maintaining brown adipocyte function for the facilitation of energy expenditure. In summary, the ACE2 pathway regulates BAT function and systemic energy metabolisms which is a potential treatment target for metabolic disorders including metabolic syndrome, diabetes, dyslipidemia, and fatty liver.</p></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><table-wrap id="keyresource" position="anchor"><label>Key resources table</label><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">Reagent type (species) or resource</th><th align="left" valign="bottom">Designation</th><th align="left" valign="bottom">Source or reference</th><th align="left" valign="bottom">Identifiers</th><th align="left" valign="bottom">Additional information</th></tr></thead><tbody><tr><td align="left" valign="bottom">Genetic reagent (<italic>Mus musculus</italic>)</td><td align="left" valign="bottom">WT C57BL/6 J</td><td align="left" valign="bottom">GemPharmatech. Co., Ltd</td><td align="left" valign="bottom">JAX 000664 RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:IMSR_JAX:000664">IMSR_JAX:000664</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>Mus musculus</italic>)</td><td align="left" valign="bottom">BKS-db (<italic>Lepr<sup>db/db</sup></italic>)</td><td align="left" valign="bottom">GemPharmatech. Co., Ltd</td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>Mus musculus</italic>)</td><td align="left" valign="bottom"><italic>Ace2</italic> KO</td><td align="left" valign="bottom">Institute of Laboratory Animal Science, Chinese Academy of Medical Sciences</td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>Mus musculus</italic>)</td><td align="left" valign="bottom"><italic>Mas1</italic> KO</td><td align="left" valign="bottom">GemPharmatech. Co., Ltd</td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Transfected construct (<italic>Mus musculus</italic>)</td><td align="left" valign="bottom">Ad-<italic>Ace2</italic>-eGFP</td><td align="left" valign="bottom">SinoGenoMax</td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Ang-(1-7)</td><td align="left" valign="bottom">MCE</td><td align="char" char="hyphen" valign="bottom">51833-78-4</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">A779</td><td align="left" valign="bottom">Selleck</td><td align="char" char="hyphen" valign="bottom">159432-28-7</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">FCCP</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">C2920</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Oligomycin A</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="char" char="ndash" valign="bottom">75351–5 MG</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Rotenone</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">R8875-1G</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">MK2206</td><td align="left" valign="bottom">Selleck</td><td align="char" char="hyphen" valign="bottom">1032350-13-2</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">H89</td><td align="left" valign="bottom">Selleck</td><td align="char" char="hyphen" valign="bottom">130964-39-5</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">SQ-22536</td><td align="left" valign="bottom">Selleck</td><td align="char" char="hyphen" valign="bottom">17318-31-9</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Other</td><td align="left" valign="bottom">Chow, 60% HFD</td><td align="left" valign="bottom">Research Diets</td><td align="left" valign="bottom">D12492</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-UCP1(rabbit polyclonal)</td><td align="left" valign="bottom">Abcam</td><td align="left" valign="bottom">#10983 RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2241462">AB_2241462</ext-link></td><td align="char" char="." valign="bottom">(1:1000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-PGC1ɑ(rabbit polyclonal)</td><td align="left" valign="bottom">Abcam</td><td align="left" valign="bottom">#54,481RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_881987">AB_881987</ext-link></td><td align="char" char="." valign="bottom">(1:1000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-OXPHOS</td><td align="left" valign="bottom">Abcam</td><td align="left" valign="bottom">#110413 RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2629281">AB_2629281</ext-link></td><td align="char" char="." valign="bottom">(1:1000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-Mas1(rabbit polyclonal)</td><td align="left" valign="bottom">Alomone</td><td align="left" valign="bottom">#AAR-013 RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2039972">AB_2039972</ext-link></td><td align="char" char="." valign="bottom">(1:1000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-Akt(rabbit polyclonal)</td><td align="left" valign="bottom">Cell signaling</td><td align="left" valign="bottom">#9272 RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_329827">AB_329827</ext-link></td><td align="char" char="." valign="bottom">(1:1000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-p-Akt308 (rabbit monoclonal)</td><td align="left" valign="bottom">Cell signaling</td><td align="left" valign="bottom">#13038 RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2629447">AB_2629447</ext-link></td><td align="char" char="." valign="bottom">(1:1000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-PKA(rabbit polyclonal)</td><td align="left" valign="bottom">Cell signaling</td><td align="left" valign="bottom">#4782 RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2170170">AB_2170170</ext-link></td><td align="char" char="." valign="bottom">(1:1000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-p-PKA(rabbit polyclonal)</td><td align="left" valign="bottom">Cell signaling</td><td align="left" valign="bottom">#9,621RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_330304">AB_330304</ext-link></td><td align="char" char="." valign="bottom">(1:1000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-ACE2(rabbit monoclonal)</td><td align="left" valign="bottom">Cell signaling</td><td align="left" valign="bottom">#92,485</td><td align="char" char="." valign="bottom">(1:1000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Actin(rabbit monoclonal)</td><td align="left" valign="bottom">Cell signaling</td><td align="left" valign="bottom">#4,970RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2223172">AB_2223172</ext-link></td><td align="char" char="." valign="bottom">(1:1000)</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom"><italic>Cidea</italic>_F</td><td align="left" valign="bottom">Invitrogen</td><td align="left" valign="bottom">RT-qPCR primer</td><td align="left" valign="bottom">TCCTATGCTGCACAGATGACG</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom"><italic>Cidea</italic>_R</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">RT-qPCR primer</td><td align="left" valign="bottom">TGCTCTTCTGTATCGCCCAGT</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom"><italic>Ppargc1</italic>a_F</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">RT-qPCR primer</td><td align="left" valign="bottom">GCACCAGAAAACAGCTCCAAG</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom"><italic>Ppargc1</italic>a_R</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">RT-qPCR primer</td><td align="left" valign="bottom">CGTCAAACACAGCTTGACAGC</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom"><italic>Ucp1</italic>_F</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">RT-qPCR primer</td><td align="left" valign="bottom">TCTCAGCCGGCTTAATGACTG</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom"><italic>Ucp1</italic>_R</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">RT-qPCR primer</td><td align="left" valign="bottom">GGCTTGCATTCTGACCTTCAC</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom"><italic>Prdm16</italic>_F</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">RT-qPCR primer</td><td align="left" valign="bottom">ACACGCCAGTTCTCCAACCTGT</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom"><italic>Prdm16</italic>_R</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">RT-qPCR primer</td><td align="left" valign="bottom">TGCTTGTTGAGGGAGGAGGTA</td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">GraphPad Prism Software</td><td align="left" valign="bottom">GraphPad Software,La Jolla, CA, USA</td><td align="left" valign="bottom">Version 8.0.0 for WindowsRRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_002798">SCR_002798</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">ANCOVA</td><td align="left" valign="bottom">PMID:<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/pubmed/30017358">30017358</ext-link></td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://calrapp.org/">https://calrapp.org/</ext-link></td><td align="left" valign="bottom"/></tr></tbody></table></table-wrap><sec id="s4-1"><title>Mice</title><p>Obese BKS-db (<italic>Lepr<sup>db/db</sup></italic>) male mice, wild-type mice and <italic>Mas1</italic> KO mice were purchased from Nanjing Biological Medicine Research Institute, Nanjing University, China. Male C57BL/6 J mice were purchased from Vital River Laboratory Animal Technology (Beijing, China). <italic>Ace2</italic> KO mice have been previously described (<xref ref-type="bibr" rid="bib23">Niu et al., 2008</xref>).</p><p>The obese diabetic <italic>Lepr<sup>db/db</sup></italic> mice at 7–8 weeks of age were used. Adenovirus (5 × 10<sup>8</sup> particle forming units (pfu) in a total volume of 100 μL of 0.9% wt/vol saline) was introduced into the <italic>Lepr<sup>db/db</sup></italic> mice by tail vein injection. The ad-<italic>Ace2 Lepr<sup>db/db</sup></italic> mice were used at the 6th day post-virus injection. The <italic>Lepr<sup>db/db</sup></italic> mice were treated with Ang-(1-7) by subcutaneous infusion of Ang-(1-7) (100 ng/kg/min) or saline using osmotic mini-pumps (Alzet-Durect, Cupertino, CA, USA Model #1004) for 4 weeks.</p><p>Six-week-old male C57BL/6 J mice were used to develop obesity by high-fat (HFD) diet (60 kcal% fat) (Research Diets, New Brunswick, NJ, USA) for 8 weeks, and the mice treated with Ang-(1-7) by osmotic mini-pumps at the 5th weeks post-HFD. Eight- to 10 weeks old male <italic>Ace2</italic> KO mice and WT controls, <italic>Mas1</italic> KO and WT controls were fed HFD diet for 8 weeks before experimental analysis. The mice were housed in a room at controlled temperature (23°C ± 1°C) with a 12-hr light-dark cycle. All animals were handled in accordance with the protocol approved by the Ethics Committee of Animal Research at Beijing Tongren Hospital, Capital Medical University, Beijing, China.</p></sec><sec id="s4-2"><title>BAT transplantation</title><p>According to the methods described previously (<xref ref-type="bibr" rid="bib17">Liu et al., 2013</xref>; <xref ref-type="bibr" rid="bib40">Yuan et al., 2016</xref>), BAT was removed from the interscapular region of 8 week old <italic>Mas1</italic> KO mice or C57BL/6 mice donor mouse and implanted into the interscapular region of recipient mice. BAT of C57B/L6 recipient mice was removed from the interscapular region. After cervical dislocation of donor mice, the BAT or eWAT (also from the epididymal fat pad of 8-week-old C57BL/6 mice) was removed and peripheral white fat was excluded, and then the remaining BAT (0.2 g) or eWAT (0.2 g) was washed with sterile PBS and transplanted into the interscapular region of recipients as quickly as possible. Recipient mice were anesthetized by ip injection with 400 mg/kg body weight avertin, and then BAT or eWAT was transplanted underneath the skin. The recipient mice were then fed an HFD, which began immediately after the transplantation and continued for 10 weeks.</p></sec><sec id="s4-3"><title>Adipocyte oxygen consumption rate (OCR) measurement</title><p>Primary brown adipose cells were isolated and cultured for 3 days before plated in XF cell culture microplates (Seahorse Bioscience). Cells (10,000 cells) were seeded in each well and each sample has eight replicates. After 6 days of differentiation, cultured adipocytes were washed twice and pre-incubated in XF medium for 2 hr at room temperature. The oxygen consumption rate was measured by the XF extracellular flux analyzer (Seahorse Biosciences). The results were normalized to protein content in each well. The process was cycled three times for baseline and drug injection measurement. Each cycle consisted of 3 min of mix, 2 min of delay, and 3 min of measurement time. The concentrations of the injection compounds used were Oligomycin (1 μM), FCCP (1 μM), and Rotenone/antimycin A (0.5 μM).</p></sec><sec id="s4-4"><title>Glucose tolerance test (GTT)</title><p>Mice were fasted for 16 hours (17:00–9:00) with free access to drinking water. Glucose (1.0 g/kg for the <italic>Lepr<sup>db/db</sup></italic> mice and 2.0 g/kg for the HFD mice) was administered intraperitoneally (i.p.), and blood glucose levels were measured immediately 0, 15, 30, 60, and 120 min after glucose injection by using an Accu-Chek glucose monitor (Roche Diagnostics Corp).</p></sec><sec id="s4-5"><title>Insulin tolerance test (ITT)</title><p>ITT was performed by injecting intraperitoneally 0.75 IU/kg of insulin at mice fasted for 1 hr and measured blood glucose levels at 0, 15, 30, 60, 90, and 120 min post injection by using an Accu-Chek glucose monitor (Roche Diagnostics Corp).</p></sec><sec id="s4-6"><title>RNA extraction and quantitative real-time RT-PCR</title><p>Total RNA was isolated using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) according to the manufacturer’s instructions. A total of 500 ng of RNA was used as the template for the first-strand cDNA synthesis using ReverTra Ace qPCR RT Kit (TOYOBO, Osaka, Japan) in accordance with the manufacturer’s protocol. The transcripts were quantified using Light Cycler 480 Real-Time PCR system (Roche, Basel, Switzerland). Primers were designed using Primer Quest (Integrated DNA Technologies, Inc).</p></sec><sec id="s4-7"><title>Positron emission tomography–computed tomography (PET-CT)</title><p>Siemens Inveon Dedicated PET (dPET) System and Inveon Multimodality (MM) System (CT/SPECT) (Siemens Preclinical Solutions) was used to detect PET-CT imaging at Chinese Academy of Medical Sciences. According to the previously studies (<xref ref-type="bibr" rid="bib17">Liu et al., 2013</xref>; <xref ref-type="bibr" rid="bib40">Yuan et al., 2016</xref>), mice were allowed to fast overnight and were lightly anesthetized with isoflurane, and then followed by a tail vein injection of 18F-FDG (500 mCi). Sixty minutes after the injection of the radiotracer, the mice were subjected to PET/CT analysis. A 10 min CT X-ray for attenuation correction was scanned before PET-CT scan. Static PET-CT scans were acquired for 10 min, and images were reconstructed by an OSEM3D algorithm followed by Maximization/Maximum a Posteriori (MAP) or Fast MAP provided by Inveon Acquisition Workplace (IAW) software. The 3D regions of interest (ROIs) were drawn over the guided CT images, and the tracer uptake was measured using Inveon Research Workplace (IRW) (Siemens) software. Individual quantification of the 18F-FDG uptake in each of the ROI was calculated. The data for the accumulation of 18F-FDG on micro-PET images were expressed as the standard uptake values (SUVs), which were determined by dividing the relevant ROI concentration by the ratio of the injected activity to the bodyweight.</p></sec><sec id="s4-8"><title>Western blot analysis</title><p>Tissues were dissolved in RIPA buffer (150 mM sodium chloride, 1.0% Triton X-100, 0.5% sodium deoxycholate, 0.1% SDS, 50 mM Tris, protease and phosphatase inhibitor mixture (Roche Diagnostics)). Protein concentrations were determined using a BCA assay kit (Pierce Diagnostics). Protein was separated by 10% (wt/vol) SDS/PAGE, transferred to a PVDF membrane (Millipore), blocked in 5% (wt/vol) skim milk in TBST (0.02 M Trisbase, 0.14 M Vehicle, 0.1% Tween 20, pH 7.4), and incubated with primary antibodies overnight at 4 °C and then incubated with secondary antibodies conjugated with HRP. The following primary antibodies were used: anti-UCP1 (ab10983, Abcam), anti-PGC1ɑ (ab54481, Abcam), anti-OXPHOS (ab110413, Abcam), anti-Mas1 (AAR-013, Alomone labs), anti-Akt (#9272, cell signaling technology), anti-p-Akt308 (#13038, cell signaling technology), anti-FoxO1 (#2880, cell signaling technology), anti-p-FoxO1 (#84192, cell signaling technology), anti-PKA (#4782, cell signaling technology), anti-p-PKA (#9621, cell signaling technology), anti-ACE2 (#92485, cell signaling technology), and actin (#4970, Cell Signaling Technology). Signals were detected with Super Signal West Pico Chemiluminescent Substrate (Pierce).</p></sec><sec id="s4-9"><title>Histology and immunofluorescence analysis</title><p>Tissues fixed in 4% paraformaldehyde were sectioned after being paraffin embedded. Multiple sections were prepared and stained with hematoxylin and eosin for general morphological observations. Cells grown on poly-L-lysine (Sigma)-pretreated coverslips were fixed with 4% paraformaldehyde. Immunofluorescence staining was performed according to the standard protocol using the following antibodies and dilutions: UCP1 (1:100 dilution; Santa Cruz Biotechnologies), MitoTracker Red (1:1,000 dilution; Invitrogen). Incubations were performed overnight in a humidified chamber at 4 °C. 40, 6-diamidino-2-phenylindole staining was used to mark the cell nuclei. The images were acquired by microscope (DS-RI1; Nikon).</p></sec><sec id="s4-10"><title>Metabolic rate and physical activity</title><p>Oxygen consumption and physical activity were determined with a TSE LabMaster, as previously described (<xref ref-type="bibr" rid="bib4">Chi and Wang, 2011</xref>). Mice were acclimated to the system for 24 hr, and then VO<sub>2</sub> and VCO<sub>2</sub> were measured during the next 24 hr. Voluntary activity of each mouse was measured with an optical beam technique (Opto-M3, Columbus Instruments, Columbus, OH, USA) over 24 hr and expressed as 24 hr average activity. Energy expenditure and respiratory exchange ratio were then calculated (<xref ref-type="bibr" rid="bib17">Liu et al., 2013</xref>).</p></sec><sec id="s4-11"><title>RNA-Seq analysis</title><p>Total RNA was extracted from <italic>Ace2</italic> KO or WT primary brown adipocytes by Trizol reagent (Invitrogen), respectively. Extracted RNA samples were sent to Novel Bioinformatics company (Shanghai, China) for RNA-seq. RNA with RIN &gt;8.0 is right for cDNA library construction. The cDNA libraries were processed for the proton sequencing according to the commercially available protocols. Data were submitted to the GEO archive. Fisher’s exact test was calculated to select the significant pathway, and the threshold of significance was defined by p-value and false discovery rate (FDR) (<xref ref-type="bibr" rid="bib10">Dupuy et al., 2007</xref>).</p></sec><sec id="s4-12"><title>Infrared thermography and core temperature</title><p>Mice were exposed to a cold chamber (4 °C) with one mouse per cage for up to 6 hr, with free access to food and water. An infrared digital thermographic camera was used to taken images (E60: Compact Infrared Thermal Imaging Camera; FLIR). The images were analyzed by FLIR Quick Report software (FLIR ResearchIR Max 3.4; FLIR). A rectal probe connected to a digital thermometer was used to measure core body temperature (Yellow Spring Instruments).</p></sec><sec id="s4-13"><title>Statistical analysis</title><p>All of the data are presented as the mean ± SEM. The data were analyzed by Student’s <italic>t</italic>-test or one-way ANOVA (with Bonferroni post-hoc tests to compare replicate means) when appropriate. Statistical comparisons were performed using Prism5 (GraphPad Software, San Diego, CA). The CLAMS data were performed using ANCOVA on webtool (<ext-link ext-link-type="uri" xlink:href="https://calrapp.org/">https://calrapp.org/</ext-link>) (<xref ref-type="bibr" rid="bib20">Mina et al., 2018</xref>). p Values less than 0.05 were considered statistically significant. Representative results from at least three independent experiments are shown unless otherwise stated.</p></sec></sec></body><back><sec id="s5" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn><fn fn-type="COI-statement" id="conf2"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Formal analysis, Funding acquisition, Investigation, Project administration, Writing – original draft, Writing – review and editing</p></fn><fn fn-type="con" id="con2"><p>Conceptualization, Formal analysis, Investigation, Writing – original draft</p></fn><fn fn-type="con" id="con3"><p>Conceptualization, Investigation, Methodology, Writing – original draft, Writing – review and editing</p></fn><fn fn-type="con" id="con4"><p>Conceptualization</p></fn><fn fn-type="con" id="con5"><p>Investigation</p></fn><fn fn-type="con" id="con6"><p>Investigation</p></fn><fn fn-type="con" id="con7"><p>Investigation</p></fn><fn fn-type="con" id="con8"><p>Investigation</p></fn><fn fn-type="con" id="con9"><p>Formal analysis, Writing – review and editing</p></fn><fn fn-type="con" id="con10"><p>Conceptualization</p></fn><fn fn-type="con" id="con11"><p>Conceptualization, Funding acquisition, Project administration, Writing – review and editing</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>All animal protocols used in this study were reviewed and approved by the Ethics Committee of Animal Research at Beijing Tongren Hospital, Capital Medical University (#2017-0107).</p></fn></fn-group></sec><sec id="s6" sec-type="supplementary-material"><title>Additional files</title><supplementary-material id="transrepform"><label>Transparent reporting form</label><media mime-subtype="docx" mimetype="application" xlink:href="elife-72266-transrepform1-v4.docx"/></supplementary-material><supplementary-material id="sdata1"><label>Source data 1.</label><caption><title>Original files for gels or blots.</title></caption><media mime-subtype="zip" mimetype="application" xlink:href="elife-72266-data1-v4.zip"/></supplementary-material><supplementary-material id="sdata2"><label>Source data 2.</label><caption><title>Powerpoint files containing gels or blots.</title></caption><media mime-subtype="zip" mimetype="application" xlink:href="elife-72266-data2-v4.zip"/></supplementary-material></sec><sec id="s7" sec-type="data-availability"><title>Data availability</title><p>All data generated or analysed during this study are included in the manuscript and supporting file.</p></sec><ack id="ack"><title>Acknowledgements</title><p>This work was supported by grants from National Key R&amp;D Program of China (2017YFC0909600) and National Natural Science Foundation of China (81561128015, 81471014) to Jinkui Yang, National Natural Science Foundation of China (81670774, 82070850) and Beijing Natural Science Foundation (7162047) to Xi Cao.</p></ack><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cao</surname><given-names>X</given-names></name><name><surname>Yang</surname><given-names>FY</given-names></name><name><surname>Xin</surname><given-names>Z</given-names></name><name><surname>Xie</surname><given-names>RR</given-names></name><name><surname>Yang</surname><given-names>JK</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>The ACE2/Ang-(1-7)/Mas axis can inhibit hepatic insulin resistance</article-title><source>Molecular and Cellular Endocrinology</source><volume>393</volume><fpage>30</fpage><lpage>38</lpage><pub-id pub-id-type="doi">10.1016/j.mce.2014.05.024</pub-id><pub-id pub-id-type="pmid">24911884</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cao</surname><given-names>X</given-names></name><name><surname>Yang</surname><given-names>F</given-names></name><name><surname>Shi</surname><given-names>T</given-names></name><name><surname>Yuan</surname><given-names>M</given-names></name><name><surname>Xin</surname><given-names>Z</given-names></name><name><surname>Xie</surname><given-names>R</given-names></name><name><surname>Li</surname><given-names>S</given-names></name><name><surname>Li</surname><given-names>H</given-names></name><name><surname>Yang</surname><given-names>JK</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Angiotensin-converting enzyme 2/angiotensin-(1-7)/Mas axis activates Akt signaling to ameliorate hepatic steatosis</article-title><source>Scientific Reports</source><volume>6</volume><elocation-id>21592</elocation-id><pub-id pub-id-type="doi">10.1038/srep21592</pub-id><pub-id pub-id-type="pmid">26883384</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cao</surname><given-names>X</given-names></name><name><surname>Lu</surname><given-names>XM</given-names></name><name><surname>Tuo</surname><given-names>X</given-names></name><name><surname>Liu</surname><given-names>JY</given-names></name><name><surname>Zhang</surname><given-names>YC</given-names></name><name><surname>Song</surname><given-names>LN</given-names></name><name><surname>Cheng</surname><given-names>ZQ</given-names></name><name><surname>Yang</surname><given-names>JK</given-names></name><name><surname>Xin</surname><given-names>Z</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Angiotensin-converting enzyme 2 regulates endoplasmic reticulum stress and mitochondrial function to preserve skeletal muscle lipid metabolism</article-title><source>Lipids in Health and Disease</source><volume>18</volume><elocation-id>207</elocation-id><pub-id pub-id-type="doi">10.1186/s12944-019-1145-x</pub-id><pub-id pub-id-type="pmid">31775868</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chi</surname><given-names>QS</given-names></name><name><surname>Wang</surname><given-names>DH</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Thermal physiology and energetics in male desert hamsters (Phodopus roborovskii) during cold acclimation</article-title><source>Journal of Comparative Physiology. B, Biochemical, Systemic, and Environmental Physiology</source><volume>181</volume><fpage>91</fpage><lpage>103</lpage><pub-id pub-id-type="doi">10.1007/s00360-010-0506-6</pub-id><pub-id pub-id-type="pmid">20714728</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chorner</surname><given-names>PM</given-names></name><name><surname>Moorehead</surname><given-names>RA</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>A-674563, a putative AKT1 inhibitor that also suppresses CDK2 activity, inhibits human NSCLC cell growth more effectively than the pan-AKT inhibitor, MK-2206</article-title><source>PLOS ONE</source><volume>13</volume><elocation-id>e0193344</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0193344</pub-id><pub-id pub-id-type="pmid">29470540</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Clarke</surname><given-names>NE</given-names></name><name><surname>Turner</surname><given-names>AJ</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Angiotensin-converting enzyme 2: the first decade</article-title><source>International Journal of Hypertension</source><volume>2012</volume><elocation-id>307315</elocation-id><pub-id pub-id-type="doi">10.1155/2012/307315</pub-id><pub-id pub-id-type="pmid">22121476</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Das</surname><given-names>UN</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Renin-angiotensin-aldosterone system in insulin resistance and metabolic syndrome</article-title><source>Journal of Translational Internal Medicine</source><volume>4</volume><fpage>66</fpage><lpage>72</lpage><pub-id pub-id-type="doi">10.1515/jtim-2016-0022</pub-id><pub-id pub-id-type="pmid">28191524</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dias-Peixoto</surname><given-names>MF</given-names></name><name><surname>Santos</surname><given-names>RAS</given-names></name><name><surname>Gomes</surname><given-names>ERM</given-names></name><name><surname>Alves</surname><given-names>MNM</given-names></name><name><surname>Almeida</surname><given-names>PWM</given-names></name><name><surname>Greco</surname><given-names>L</given-names></name><name><surname>Rosa</surname><given-names>M</given-names></name><name><surname>Fauler</surname><given-names>B</given-names></name><name><surname>Bader</surname><given-names>M</given-names></name><name><surname>Alenina</surname><given-names>N</given-names></name><name><surname>Guatimosim</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Molecular mechanisms involved in the angiotensin-(1-7)/Mas signaling pathway in cardiomyocytes</article-title><source>Hypertension</source><volume>52</volume><fpage>542</fpage><lpage>548</lpage><pub-id pub-id-type="doi">10.1161/HYPERTENSIONAHA.108.114280</pub-id><pub-id pub-id-type="pmid">18695148</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dong</surname><given-names>M</given-names></name><name><surname>Lin</surname><given-names>J</given-names></name><name><surname>Lim</surname><given-names>W</given-names></name><name><surname>Jin</surname><given-names>W</given-names></name><name><surname>Lee</surname><given-names>HJ</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Role of brown adipose tissue in metabolic syndrome, aging, and cancer cachexia</article-title><source>Frontiers of Medicine</source><volume>12</volume><fpage>130</fpage><lpage>138</lpage><pub-id pub-id-type="doi">10.1007/s11684-017-0555-2</pub-id><pub-id pub-id-type="pmid">29119382</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dupuy</surname><given-names>D</given-names></name><name><surname>Bertin</surname><given-names>N</given-names></name><name><surname>Hidalgo</surname><given-names>CA</given-names></name><name><surname>Venkatesan</surname><given-names>K</given-names></name><name><surname>Tu</surname><given-names>D</given-names></name><name><surname>Lee</surname><given-names>D</given-names></name><name><surname>Rosenberg</surname><given-names>J</given-names></name><name><surname>Svrzikapa</surname><given-names>N</given-names></name><name><surname>Blanc</surname><given-names>A</given-names></name><name><surname>Carnec</surname><given-names>A</given-names></name><name><surname>Carvunis</surname><given-names>A-R</given-names></name><name><surname>Pulak</surname><given-names>R</given-names></name><name><surname>Shingles</surname><given-names>J</given-names></name><name><surname>Reece-Hoyes</surname><given-names>J</given-names></name><name><surname>Hunt-Newbury</surname><given-names>R</given-names></name><name><surname>Viveiros</surname><given-names>R</given-names></name><name><surname>Mohler</surname><given-names>WA</given-names></name><name><surname>Tasan</surname><given-names>M</given-names></name><name><surname>Roth</surname><given-names>FP</given-names></name><name><surname>Le Peuch</surname><given-names>C</given-names></name><name><surname>Hope</surname><given-names>IA</given-names></name><name><surname>Johnsen</surname><given-names>R</given-names></name><name><surname>Moerman</surname><given-names>DG</given-names></name><name><surname>Barabási</surname><given-names>A-L</given-names></name><name><surname>Baillie</surname><given-names>D</given-names></name><name><surname>Vidal</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Genome-scale analysis of in vivo spatiotemporal promoter activity in <italic>Caenorhabditis elegans</italic></article-title><source>Nature Biotechnology</source><volume>25</volume><fpage>663</fpage><lpage>668</lpage><pub-id pub-id-type="doi">10.1038/nbt1305</pub-id><pub-id pub-id-type="pmid">17486083</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gomes</surname><given-names>ERM</given-names></name><name><surname>Santos</surname><given-names>RAS</given-names></name><name><surname>Guatimosim</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Angiotensin-(1-7)-mediated signaling in cardiomyocytes</article-title><source>International Journal of Hypertension</source><volume>2012</volume><elocation-id>493129</elocation-id><pub-id pub-id-type="doi">10.1155/2012/493129</pub-id><pub-id pub-id-type="pmid">22518286</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hashimoto</surname><given-names>T</given-names></name><name><surname>Perlot</surname><given-names>T</given-names></name><name><surname>Rehman</surname><given-names>A</given-names></name><name><surname>Trichereau</surname><given-names>J</given-names></name><name><surname>Ishiguro</surname><given-names>H</given-names></name><name><surname>Paolino</surname><given-names>M</given-names></name><name><surname>Sigl</surname><given-names>V</given-names></name><name><surname>Hanada</surname><given-names>T</given-names></name><name><surname>Hanada</surname><given-names>R</given-names></name><name><surname>Lipinski</surname><given-names>S</given-names></name><name><surname>Wild</surname><given-names>B</given-names></name><name><surname>Camargo</surname><given-names>SMR</given-names></name><name><surname>Singer</surname><given-names>D</given-names></name><name><surname>Richter</surname><given-names>A</given-names></name><name><surname>Kuba</surname><given-names>K</given-names></name><name><surname>Fukamizu</surname><given-names>A</given-names></name><name><surname>Schreiber</surname><given-names>S</given-names></name><name><surname>Clevers</surname><given-names>H</given-names></name><name><surname>Verrey</surname><given-names>F</given-names></name><name><surname>Rosenstiel</surname><given-names>P</given-names></name><name><surname>Penninger</surname><given-names>JM</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>ACE2 links amino acid malnutrition to microbial ecology and intestinal inflammation</article-title><source>Nature</source><volume>487</volume><fpage>477</fpage><lpage>481</lpage><pub-id pub-id-type="doi">10.1038/nature11228</pub-id><pub-id pub-id-type="pmid">22837003</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kawabe</surname><given-names>Y</given-names></name><name><surname>Mori</surname><given-names>J</given-names></name><name><surname>Morimoto</surname><given-names>H</given-names></name><name><surname>Yamaguchi</surname><given-names>M</given-names></name><name><surname>Miyagaki</surname><given-names>S</given-names></name><name><surname>Ota</surname><given-names>T</given-names></name><name><surname>Tsuma</surname><given-names>Y</given-names></name><name><surname>Fukuhara</surname><given-names>S</given-names></name><name><surname>Nakajima</surname><given-names>H</given-names></name><name><surname>Oudit</surname><given-names>GY</given-names></name><name><surname>Hosoi</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>ACE2 exerts anti-obesity effect via stimulating brown adipose tissue and induction of browning in white adipose tissue</article-title><source>American Journal of Physiology. Endocrinology and Metabolism</source><volume>317</volume><fpage>E1140</fpage><lpage>E1149</lpage><pub-id pub-id-type="doi">10.1152/ajpendo.00311.2019</pub-id><pub-id pub-id-type="pmid">31638856</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lavoie</surname><given-names>JL</given-names></name><name><surname>Sigmund</surname><given-names>CD</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Minireview: overview of the renin-angiotensin system--an endocrine and paracrine system</article-title><source>Endocrinology</source><volume>144</volume><fpage>2179</fpage><lpage>2183</lpage><pub-id pub-id-type="doi">10.1210/en.2003-0150</pub-id><pub-id pub-id-type="pmid">12746271</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>C</given-names></name><name><surname>Lv</surname><given-names>XH</given-names></name><name><surname>Li</surname><given-names>HX</given-names></name><name><surname>Cao</surname><given-names>X</given-names></name><name><surname>Zhang</surname><given-names>F</given-names></name><name><surname>Wang</surname><given-names>L</given-names></name><name><surname>Yu</surname><given-names>M</given-names></name><name><surname>Yang</surname><given-names>JK</given-names></name></person-group><year iso-8601-date="2012">2012a</year><article-title>Angiotensin-(1-7) suppresses oxidative stress and improves glucose uptake via Mas receptor in adipocytes</article-title><source>Acta Diabetologica</source><volume>49</volume><fpage>291</fpage><lpage>299</lpage><pub-id pub-id-type="doi">10.1007/s00592-011-0348-z</pub-id><pub-id pub-id-type="pmid">22042130</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>GC</given-names></name><name><surname>Oudit</surname><given-names>GY</given-names></name><name><surname>Fang</surname><given-names>F</given-names></name><name><surname>Zhou</surname><given-names>J</given-names></name><name><surname>Scholey</surname><given-names>JW</given-names></name></person-group><year iso-8601-date="2012">2012b</year><article-title>Angiotensin-(1-7)-induced activation of ERK1/2 is cAMP/protein kinase A-dependent in glomerular mesangial cells</article-title><source>American Journal of Physiology. Renal Physiology</source><volume>302</volume><fpage>F784</fpage><lpage>F790</lpage><pub-id pub-id-type="doi">10.1152/ajprenal.00455.2011</pub-id><pub-id pub-id-type="pmid">22189944</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>X</given-names></name><name><surname>Zheng</surname><given-names>Z</given-names></name><name><surname>Zhu</surname><given-names>X</given-names></name><name><surname>Meng</surname><given-names>M</given-names></name><name><surname>Li</surname><given-names>L</given-names></name><name><surname>Shen</surname><given-names>Y</given-names></name><name><surname>Chi</surname><given-names>Q</given-names></name><name><surname>Wang</surname><given-names>D</given-names></name><name><surname>Zhang</surname><given-names>Z</given-names></name><name><surname>Li</surname><given-names>C</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Xue</surname><given-names>Y</given-names></name><name><surname>Speakman</surname><given-names>JR</given-names></name><name><surname>Jin</surname><given-names>W</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Brown adipose tissue transplantation improves whole-body energy metabolism</article-title><source>Cell Research</source><volume>23</volume><fpage>851</fpage><lpage>854</lpage><pub-id pub-id-type="doi">10.1038/cr.2013.64</pub-id><pub-id pub-id-type="pmid">23649313</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Magaldi</surname><given-names>AJ</given-names></name><name><surname>Cesar</surname><given-names>KR</given-names></name><name><surname>de Araújo</surname><given-names>M</given-names></name><name><surname>Simões e Silva</surname><given-names>AC</given-names></name><name><surname>Santos</surname><given-names>RAS</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Angiotensin-(1-7) stimulates water transport in rat inner medullary collecting duct: evidence for involvement of vasopressin V2 receptors</article-title><source>Pflugers Archiv</source><volume>447</volume><fpage>223</fpage><lpage>230</lpage><pub-id pub-id-type="doi">10.1007/s00424-003-1173-1</pub-id><pub-id pub-id-type="pmid">14534790</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matsuzaki</surname><given-names>S</given-names></name><name><surname>Pouly</surname><given-names>JL</given-names></name><name><surname>Canis</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>In vitro and in vivo effects of MK2206 and chloroquine combination therapy on endometriosis: autophagy may be required for regrowth of endometriosis</article-title><source>British Journal of Pharmacology</source><volume>175</volume><fpage>1637</fpage><lpage>1653</lpage><pub-id pub-id-type="doi">10.1111/bph.14170</pub-id><pub-id pub-id-type="pmid">29457968</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mina</surname><given-names>AI</given-names></name><name><surname>LeClair</surname><given-names>RA</given-names></name><name><surname>LeClair</surname><given-names>KB</given-names></name><name><surname>Cohen</surname><given-names>DE</given-names></name><name><surname>Lantier</surname><given-names>L</given-names></name><name><surname>Banks</surname><given-names>AS</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>CalR: A Web-Based Analysis Tool for Indirect Calorimetry Experiments</article-title><source>Cell Metabolism</source><volume>28</volume><fpage>656</fpage><lpage>666</lpage><pub-id pub-id-type="doi">10.1016/j.cmet.2018.06.019</pub-id><pub-id pub-id-type="pmid">30017358</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morimoto</surname><given-names>H</given-names></name><name><surname>Mori</surname><given-names>J</given-names></name><name><surname>Nakajima</surname><given-names>H</given-names></name><name><surname>Kawabe</surname><given-names>Y</given-names></name><name><surname>Tsuma</surname><given-names>Y</given-names></name><name><surname>Fukuhara</surname><given-names>S</given-names></name><name><surname>Kodo</surname><given-names>K</given-names></name><name><surname>Ikoma</surname><given-names>K</given-names></name><name><surname>Matoba</surname><given-names>S</given-names></name><name><surname>Oudit</surname><given-names>GY</given-names></name><name><surname>Hosoi</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Angiotensin 1-7 stimulates brown adipose tissue and reduces diet-induced obesity</article-title><source>American Journal of Physiology. Endocrinology and Metabolism</source><volume>314</volume><fpage>E131</fpage><lpage>E138</lpage><pub-id pub-id-type="doi">10.1152/ajpendo.00192.2017</pub-id><pub-id pub-id-type="pmid">29066463</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nakae</surname><given-names>J</given-names></name><name><surname>Cao</surname><given-names>Y</given-names></name><name><surname>Oki</surname><given-names>M</given-names></name><name><surname>Orba</surname><given-names>Y</given-names></name><name><surname>Sawa</surname><given-names>H</given-names></name><name><surname>Kiyonari</surname><given-names>H</given-names></name><name><surname>Iskandar</surname><given-names>K</given-names></name><name><surname>Suga</surname><given-names>K</given-names></name><name><surname>Lombes</surname><given-names>M</given-names></name><name><surname>Hayashi</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Forkhead transcription factor FoxO1 in adipose tissue regulates energy storage and expenditure</article-title><source>Diabetes</source><volume>57</volume><fpage>563</fpage><lpage>576</lpage><pub-id pub-id-type="doi">10.2337/db07-0698</pub-id><pub-id pub-id-type="pmid">18162510</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Niu</surname><given-names>MJ</given-names></name><name><surname>Yang</surname><given-names>JK</given-names></name><name><surname>Lin</surname><given-names>SS</given-names></name><name><surname>Ji</surname><given-names>XJ</given-names></name><name><surname>Guo</surname><given-names>LM</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Loss of angiotensin-converting enzyme 2 leads to impaired glucose homeostasis in mice</article-title><source>Endocrine</source><volume>34</volume><fpage>56</fpage><lpage>61</lpage><pub-id pub-id-type="doi">10.1007/s12020-008-9110-x</pub-id><pub-id pub-id-type="pmid">18956256</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ortega-Molina</surname><given-names>A</given-names></name><name><surname>Efeyan</surname><given-names>A</given-names></name><name><surname>Lopez-Guadamillas</surname><given-names>E</given-names></name><name><surname>Muñoz-Martin</surname><given-names>M</given-names></name><name><surname>Gómez-López</surname><given-names>G</given-names></name><name><surname>Cañamero</surname><given-names>M</given-names></name><name><surname>Mulero</surname><given-names>F</given-names></name><name><surname>Pastor</surname><given-names>J</given-names></name><name><surname>Martinez</surname><given-names>S</given-names></name><name><surname>Romanos</surname><given-names>E</given-names></name><name><surname>Mar Gonzalez-Barroso</surname><given-names>M</given-names></name><name><surname>Rial</surname><given-names>E</given-names></name><name><surname>Valverde</surname><given-names>AM</given-names></name><name><surname>Bischoff</surname><given-names>JR</given-names></name><name><surname>Serrano</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Pten positively regulates brown adipose function, energy expenditure, and longevity</article-title><source>Cell Metabolism</source><volume>15</volume><fpage>382</fpage><lpage>394</lpage><pub-id pub-id-type="doi">10.1016/j.cmet.2012.02.001</pub-id><pub-id pub-id-type="pmid">22405073</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Puigserver</surname><given-names>P</given-names></name><name><surname>Wu</surname><given-names>Z</given-names></name><name><surname>Park</surname><given-names>CW</given-names></name><name><surname>Graves</surname><given-names>R</given-names></name><name><surname>Wright</surname><given-names>M</given-names></name><name><surname>Spiegelman</surname><given-names>BM</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis</article-title><source>Cell</source><volume>92</volume><fpage>829</fpage><lpage>839</lpage><pub-id pub-id-type="doi">10.1016/s0092-8674(00)81410-5</pub-id><pub-id pub-id-type="pmid">9529258</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sahr</surname><given-names>A</given-names></name><name><surname>Wolke</surname><given-names>C</given-names></name><name><surname>Maczewsky</surname><given-names>J</given-names></name><name><surname>Krippeit-Drews</surname><given-names>P</given-names></name><name><surname>Tetzner</surname><given-names>A</given-names></name><name><surname>Drews</surname><given-names>G</given-names></name><name><surname>Venz</surname><given-names>S</given-names></name><name><surname>Gürtler</surname><given-names>S</given-names></name><name><surname>van den Brandt</surname><given-names>J</given-names></name><name><surname>Berg</surname><given-names>S</given-names></name><name><surname>Döring</surname><given-names>P</given-names></name><name><surname>Dombrowski</surname><given-names>F</given-names></name><name><surname>Walther</surname><given-names>T</given-names></name><name><surname>Lendeckel</surname><given-names>U</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>The Angiotensin-(1-7)/Mas Axis Improves Pancreatic β-Cell Function in Vitro and in Vivo</article-title><source>Endocrinology</source><volume>157</volume><fpage>4677</fpage><lpage>4690</lpage><pub-id pub-id-type="doi">10.1210/en.2016-1247</pub-id><pub-id pub-id-type="pmid">27715254</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sambeat</surname><given-names>A</given-names></name><name><surname>Gulyaeva</surname><given-names>O</given-names></name><name><surname>Dempersmier</surname><given-names>J</given-names></name><name><surname>Tharp</surname><given-names>KM</given-names></name><name><surname>Stahl</surname><given-names>A</given-names></name><name><surname>Paul</surname><given-names>SM</given-names></name><name><surname>Sul</surname><given-names>HS</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>LSD1 Interacts with Zfp516 to Promote UCP1 Transcription and Brown Fat Program</article-title><source>Cell Reports</source><volume>15</volume><fpage>2536</fpage><lpage>2549</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2016.05.019</pub-id><pub-id pub-id-type="pmid">27264172</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Santos</surname><given-names>RAS</given-names></name><name><surname>Simoes e Silva</surname><given-names>AC</given-names></name><name><surname>Maric</surname><given-names>C</given-names></name><name><surname>Silva</surname><given-names>DMR</given-names></name><name><surname>Machado</surname><given-names>RP</given-names></name><name><surname>de Buhr</surname><given-names>I</given-names></name><name><surname>Heringer-Walther</surname><given-names>S</given-names></name><name><surname>Pinheiro</surname><given-names>SVB</given-names></name><name><surname>Lopes</surname><given-names>MT</given-names></name><name><surname>Bader</surname><given-names>M</given-names></name><name><surname>Mendes</surname><given-names>EP</given-names></name><name><surname>Lemos</surname><given-names>VS</given-names></name><name><surname>Campagnole-Santos</surname><given-names>MJ</given-names></name><name><surname>Schultheiss</surname><given-names>HP</given-names></name><name><surname>Speth</surname><given-names>R</given-names></name><name><surname>Walther</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas</article-title><source>PNAS</source><volume>100</volume><fpage>8258</fpage><lpage>8263</lpage><pub-id pub-id-type="doi">10.1073/pnas.1432869100</pub-id><pub-id pub-id-type="pmid">12829792</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schreiber</surname><given-names>R</given-names></name><name><surname>Diwoky</surname><given-names>C</given-names></name><name><surname>Schoiswohl</surname><given-names>G</given-names></name><name><surname>Feiler</surname><given-names>U</given-names></name><name><surname>Wongsiriroj</surname><given-names>N</given-names></name><name><surname>Abdellatif</surname><given-names>M</given-names></name><name><surname>Kolb</surname><given-names>D</given-names></name><name><surname>Hoeks</surname><given-names>J</given-names></name><name><surname>Kershaw</surname><given-names>EE</given-names></name><name><surname>Sedej</surname><given-names>S</given-names></name><name><surname>Schrauwen</surname><given-names>P</given-names></name><name><surname>Haemmerle</surname><given-names>G</given-names></name><name><surname>Zechner</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Cold-Induced Thermogenesis Depends on ATGL-Mediated Lipolysis in Cardiac Muscle, but Not Brown Adipose Tissue</article-title><source>Cell Metabolism</source><volume>26</volume><fpage>753</fpage><lpage>763</lpage><pub-id pub-id-type="doi">10.1016/j.cmet.2017.09.004</pub-id><pub-id pub-id-type="pmid">28988821</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shi</surname><given-names>TT</given-names></name><name><surname>Yang</surname><given-names>FY</given-names></name><name><surname>Liu</surname><given-names>C</given-names></name><name><surname>Cao</surname><given-names>X</given-names></name><name><surname>Lu</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>XL</given-names></name><name><surname>Yuan</surname><given-names>MX</given-names></name><name><surname>Chen</surname><given-names>C</given-names></name><name><surname>Yang</surname><given-names>JK</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Angiotensin-converting enzyme 2 regulates mitochondrial function in pancreatic β-cells</article-title><source>Biochemical and Biophysical Research Communications</source><volume>495</volume><fpage>860</fpage><lpage>866</lpage><pub-id pub-id-type="doi">10.1016/j.bbrc.2017.11.055</pub-id><pub-id pub-id-type="pmid">29128354</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Song</surname><given-names>LN</given-names></name><name><surname>Liu</surname><given-names>JY</given-names></name><name><surname>Shi</surname><given-names>TT</given-names></name><name><surname>Zhang</surname><given-names>YC</given-names></name><name><surname>Xin</surname><given-names>Z</given-names></name><name><surname>Cao</surname><given-names>X</given-names></name><name><surname>Yang</surname><given-names>JK</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Angiotensin-(1-7), the product of ACE2 ameliorates NAFLD by acting through its receptor Mas to regulate hepatic mitochondrial function and glycolipid metabolism</article-title><source>FASEB Journal</source><volume>34</volume><fpage>16291</fpage><lpage>16306</lpage><pub-id pub-id-type="doi">10.1096/fj.202001639R</pub-id><pub-id pub-id-type="pmid">33078906</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Su</surname><given-names>J</given-names></name><name><surname>Wu</surname><given-names>W</given-names></name><name><surname>Huang</surname><given-names>S</given-names></name><name><surname>Xue</surname><given-names>R</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Wan</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>L</given-names></name><name><surname>Qin</surname><given-names>L</given-names></name><name><surname>Zhang</surname><given-names>Q</given-names></name><name><surname>Zhu</surname><given-names>X</given-names></name><name><surname>Zhang</surname><given-names>Z</given-names></name><name><surname>Ye</surname><given-names>H</given-names></name><name><surname>Wu</surname><given-names>X</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>PKA-RIIB Deficiency Induces Brown Fatlike Adipocytes in Inguinal WAT and Promotes Energy Expenditure in Male FVB/NJ Mice</article-title><source>Endocrinology</source><volume>158</volume><fpage>578</fpage><lpage>591</lpage><pub-id pub-id-type="doi">10.1210/en.2016-1581</pub-id><pub-id pub-id-type="pmid">27967236</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Than</surname><given-names>A</given-names></name><name><surname>Leow</surname><given-names>MK-S</given-names></name><name><surname>Chen</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Control of adipogenesis by the autocrine interplays between angiotensin 1-7/Mas receptor and angiotensin II/AT1 receptor signaling pathways</article-title><source>The Journal of Biological Chemistry</source><volume>288</volume><fpage>15520</fpage><lpage>15531</lpage><pub-id pub-id-type="doi">10.1074/jbc.M113.459792</pub-id><pub-id pub-id-type="pmid">23592774</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Than</surname><given-names>A</given-names></name><name><surname>Xu</surname><given-names>S</given-names></name><name><surname>Li</surname><given-names>R</given-names></name><name><surname>Leow</surname><given-names>MKS</given-names></name><name><surname>Sun</surname><given-names>L</given-names></name><name><surname>Chen</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Angiotensin type 2 receptor activation promotes browning of white adipose tissue and brown adipogenesis</article-title><source>Signal Transduction and Targeted Therapy</source><volume>2</volume><elocation-id>17022</elocation-id><pub-id pub-id-type="doi">10.1038/sigtrans.2017.22</pub-id><pub-id pub-id-type="pmid">29263921</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tiraby</surname><given-names>C</given-names></name><name><surname>Tavernier</surname><given-names>G</given-names></name><name><surname>Lefort</surname><given-names>C</given-names></name><name><surname>Larrouy</surname><given-names>D</given-names></name><name><surname>Bouillaud</surname><given-names>F</given-names></name><name><surname>Ricquier</surname><given-names>D</given-names></name><name><surname>Langin</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Acquirement of brown fat cell features by human white adipocytes</article-title><source>The Journal of Biological Chemistry</source><volume>278</volume><fpage>33370</fpage><lpage>33376</lpage><pub-id pub-id-type="doi">10.1074/jbc.M305235200</pub-id><pub-id pub-id-type="pmid">12807871</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tirupula</surname><given-names>KC</given-names></name><name><surname>Desnoyer</surname><given-names>R</given-names></name><name><surname>Speth</surname><given-names>RC</given-names></name><name><surname>Karnik</surname><given-names>SS</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Atypical signaling and functional desensitization response of MAS receptor to peptide ligands</article-title><source>PLOS ONE</source><volume>9</volume><elocation-id>e103520</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0103520</pub-id><pub-id pub-id-type="pmid">25068582</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trayhurn</surname><given-names>P</given-names></name><name><surname>Wusteman</surname><given-names>MC</given-names></name></person-group><year iso-8601-date="1990">1990</year><article-title>Lipogenesis in genetically diabetic (db/db) mice: developmental changes in brown adipose tissue, white adipose tissue and the liver</article-title><source>Biochimica et Biophysica Acta</source><volume>1047</volume><fpage>168</fpage><lpage>174</lpage><pub-id pub-id-type="doi">10.1016/0005-2760(90)90043-w</pub-id><pub-id pub-id-type="pmid">2248973</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>JK</given-names></name><name><surname>Feng</surname><given-names>Y</given-names></name><name><surname>Yuan</surname><given-names>MY</given-names></name><name><surname>Yuan</surname><given-names>SY</given-names></name><name><surname>Fu</surname><given-names>HJ</given-names></name><name><surname>Wu</surname><given-names>BY</given-names></name><name><surname>Sun</surname><given-names>GZ</given-names></name><name><surname>Yang</surname><given-names>GR</given-names></name><name><surname>Zhang</surname><given-names>XL</given-names></name><name><surname>Wang</surname><given-names>L</given-names></name><name><surname>Xu</surname><given-names>X</given-names></name><name><surname>Xu</surname><given-names>XP</given-names></name><name><surname>Chan</surname><given-names>JCN</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Plasma glucose levels and diabetes are independent predictors for mortality and morbidity in patients with SARS</article-title><source>Diabetic Medicine</source><volume>23</volume><fpage>623</fpage><lpage>628</lpage><pub-id pub-id-type="doi">10.1111/j.1464-5491.2006.01861.x</pub-id><pub-id pub-id-type="pmid">16759303</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>JK</given-names></name><name><surname>Lu</surname><given-names>J</given-names></name><name><surname>Yuan</surname><given-names>SS</given-names></name><name><surname>Cao</surname><given-names>X</given-names></name><name><surname>Qiu</surname><given-names>HY</given-names></name><name><surname>Shi</surname><given-names>TT</given-names></name><name><surname>Yang</surname><given-names>FY</given-names></name><name><surname>Li</surname><given-names>Q</given-names></name><name><surname>Liu</surname><given-names>CP</given-names></name><name><surname>Wu</surname><given-names>Q</given-names></name><name><surname>Wang</surname><given-names>YH</given-names></name><name><surname>Huang</surname><given-names>HX</given-names></name><name><surname>Kayoumu</surname><given-names>A</given-names></name><name><surname>Feng</surname><given-names>JP</given-names></name><name><surname>Xie</surname><given-names>RR</given-names></name><name><surname>Zhu</surname><given-names>XR</given-names></name><name><surname>Liu</surname><given-names>C</given-names></name><name><surname>Yang</surname><given-names>GR</given-names></name><name><surname>Zhang</surname><given-names>MR</given-names></name><name><surname>Xie</surname><given-names>CL</given-names></name><name><surname>Chen</surname><given-names>C</given-names></name><name><surname>Zhang</surname><given-names>B</given-names></name><name><surname>Liu</surname><given-names>G</given-names></name><name><surname>Zhang</surname><given-names>XQ</given-names></name><name><surname>Xu</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>From Hyper- to Hypoinsulinemia and Diabetes: Effect of KCNH6 on Insulin Secretion</article-title><source>Cell Reports</source><volume>25</volume><fpage>3800</fpage><lpage>3810</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2018.12.005</pub-id><pub-id pub-id-type="pmid">30590050</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yuan</surname><given-names>X</given-names></name><name><surname>Hu</surname><given-names>T</given-names></name><name><surname>Zhao</surname><given-names>H</given-names></name><name><surname>Huang</surname><given-names>Y</given-names></name><name><surname>Ye</surname><given-names>R</given-names></name><name><surname>Lin</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>C</given-names></name><name><surname>Zhang</surname><given-names>H</given-names></name><name><surname>Wei</surname><given-names>G</given-names></name><name><surname>Zhou</surname><given-names>H</given-names></name><name><surname>Dong</surname><given-names>M</given-names></name><name><surname>Zhao</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>Liu</surname><given-names>Q</given-names></name><name><surname>Lee</surname><given-names>HJ</given-names></name><name><surname>Jin</surname><given-names>W</given-names></name><name><surname>Chen</surname><given-names>ZJ</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Brown adipose tissue transplantation ameliorates polycystic ovary syndrome</article-title><source>PNAS</source><volume>113</volume><fpage>2708</fpage><lpage>2713</lpage><pub-id pub-id-type="doi">10.1073/pnas.1523236113</pub-id><pub-id pub-id-type="pmid">26903641</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Z</given-names></name><name><surname>Zhang</surname><given-names>H</given-names></name><name><surname>Li</surname><given-names>B</given-names></name><name><surname>Meng</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Yao</surname><given-names>S</given-names></name><name><surname>Ma</surname><given-names>Q</given-names></name><name><surname>Jin</surname><given-names>L</given-names></name><name><surname>Yang</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>W</given-names></name><name><surname>Ning</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Berberine activates thermogenesis in white and brown adipose tissue</article-title><source>Nature Communications</source><volume>5</volume><elocation-id>5493</elocation-id><pub-id pub-id-type="doi">10.1038/ncomms6493</pub-id><pub-id pub-id-type="pmid">25423280</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>F</given-names></name><name><surname>Liu</surname><given-names>C</given-names></name><name><surname>Wang</surname><given-names>L</given-names></name><name><surname>Cao</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>YY</given-names></name><name><surname>Yang</surname><given-names>JK</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Antioxidant effect of angiotensin (1‑7) in the protection of pancreatic β cell function</article-title><source>Molecular Medicine Reports</source><volume>14</volume><fpage>1963</fpage><lpage>1969</lpage><pub-id pub-id-type="doi">10.3892/mmr.2016.5514</pub-id><pub-id pub-id-type="pmid">27430410</pub-id></element-citation></ref></ref-list></back><sub-article article-type="editor-report" id="sa0"><front-stub><article-id pub-id-type="doi">10.7554/eLife.72266.sa0</article-id><title-group><article-title>Editor's evaluation</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Napoli</surname><given-names>Nicola</given-names></name><role specific-use="editor">Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/04gqx4x78</institution-id><institution>Campus Bio-Medico University of Rome</institution></institution-wrap><country>Italy</country></aff></contrib></contrib-group><related-object id="sa0ro1" link-type="continued-by" object-id="10.1101/2021.08.10.455823" object-id-type="id" xlink:href="https://sciety.org/articles/activity/10.1101/2021.08.10.455823"/></front-stub><body><p>Authors have found that ACE2 is highly expressed in brown adipose tissue (BAT), indicating ACE2 pathway as a critical regulator in the maintenance of thermogenesis and energy expenditure. Identifying new regulators of energy homeostasis authors have shed light on novel potential therapeutic targets for the treatment of metabolic disorders.</p></body></sub-article><sub-article article-type="decision-letter" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.72266.sa1</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Napoli</surname><given-names>Nicola</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/04gqx4x78</institution-id><institution>Campus Bio-Medico University of Rome</institution></institution-wrap><country>Italy</country></aff></contrib></contrib-group></front-stub><body><boxed-text id="box1"><p>Our editorial process produces two outputs: i) <ext-link ext-link-type="uri" xlink:href="https://sciety.org/articles/activity/10.1101/2021.08.10.455823">public reviews</ext-link> designed to be posted alongside <ext-link ext-link-type="uri" xlink:href="https://www.biorxiv.org/content/10.1101/2021.08.10.455823v1">the preprint</ext-link> for the benefit of readers; ii) feedback on the manuscript for the authors, including requests for revisions, shown below. We also include an acceptance summary that explains what the editors found interesting or important about the work.</p></boxed-text><p><bold>Decision letter after peer review:</bold></p><p>Thank you for submitting your article &quot;ACE2 Pathway Regulates Thermogenesis and Energy Metabolism&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by 2 peer reviewers, and the evaluation has been overseen by a Reviewing Editor and Carlos Isales as the Senior Editor. The reviewers have opted to remain anonymous.</p><p>The reviewers have discussed their reviews with one another, and the Reviewing Editor has drafted this to help you prepare a revised submission.</p><p>Essential revisions:</p><p>1) Body temperature experiments in ACE2-overexpressing mice in the HFD model</p><p>2) Experiments to clarify the relationship between PKA and AKT signaling, RAS signaling and respiration</p><p><italic>Reviewer #1 (Recommendations for the authors):</italic></p><p>1) The authors provide ample evidence that both AKT signaling and PKA signaling contribute to RAS signaling upregulation of UCP1 and mitochondrial respiration. In their model, they have the AKT and PKA pathways as unrelated inputs into mitochondrial respiration. However, primary BATs treated with PKA and AKT inhibitors seem have a similar total loss of RAS-induced oxygen consumption. This either implies that they are either part of the same pathway (not unrelated) or that AKT and PKA inhibitors are shutting off respiration in general and that this is not related to RAS-induced respiration in particular. Some experiments to clarify the relationship between PKA and AKT signaling, RAS signaling and respiration would be helpful. For example, does co-treatment with AKT and PKA inhibitors have an additive effect? Do these inhibitors have an effect on respiration independent of Ang-(1-7) treatment. It may be interesting to see if Ang-(1-7) treated cells respond differently to A779 treatment than PKA or AKT inhibition in terms of mitochondrial respiration to determine the magnitude of the effect on respiration of PKAi/AKTi are similar to the effect of a RASi. It may be valuable to use adipocytes from the diabetic mice and induce Ace2 in those mice, then observe how AKT and PKA inhibitors effect respiration in cells that have low basal RAS activity.</p><p>2) Figure 2I and 3I should be quantified-though I believe that there is less UCP1 expression upon loss of Ace2 and more upon Ace2 overexpression, it is hard to tell visually and is certainly not obvious. Other histology stains, such as figures 5A, C, and E could also be quantified to provide additional certainty that the effect described is significant.</p><p>3) A critical issue is the lack of discussion and context in the introduction and discussion that places this work in context of the literature about RAS and energy expenditure. I recommend expanding the introduction and/or discussion to include this critical background. For example, previous work (PMID: 31638856 and 29066463) has found that RAS activation induced browning and energy expenditure which is surely relevant for the work described here, but it is not cited or discussed how these studies relate to the manuscript.</p><p><italic>Reviewer #2 (Recommendations for the authors):</italic></p><p>This is a strong paper with clear experimental evidence to support most claims put forth within the abstract (as outlined in the public review). There are a handful of points that I believe the authors should consider and/or address before final publication of this study:</p><p>1. Modifying the claims in the abstract. Most claims are well supported with evidence in the paper, as outlined in the public review. Two exceptions are:</p><p>Claim 1: &quot;ACE2 knockout mice (ACE2-/y), Mas knockout mice (Mas-/-) and mice transplanted with brown adipose tissue from Mas-/- mice displayed impaired thermogenesis.&quot;</p><p>The authors show that wild type C57BL/6 mice transplanted with BAT from Mas-/- mice show metabolic impairments consistent with ACE2-/y and Mas-/- mice, but do not show data regarding their body temperature. This claim can be addressed by performing body temperature experiments similar to those performed in Figures 2F or 3F. Alternatively, the authors can restate their claim to state that &quot;mice transplanted with brown adipose tissue from Mas-/- display metabolic abnormalities consistent with those seen in the ACE2 and Mas knockout mice.&quot;</p><p>Claim 2: &quot;…impaired thermogenesis of db/db obese diabetic mice and high-fat diet-induced obese mice were ameliorated by overexpression of ACE2 or continuous fusion of Ang-(1-7).&quot;</p><p>The authors also show that infusion of Ang-(1-7) can increase body temperature acutely after cold challenge in mice fed a high fat diet (HFD) (Figure 4H), but they do not test the effects of overexpression of ACE2 on body temperature in the HFD model. The authors can address this by either performing the body temperature experiments in ACE2-overexpressing mice in the HFD model, or reword this claim to avoid confusion over this distinction.</p><p>2. Analyzing metabolic data according to the ANCOVA method. The authors use a TSE LabMaster to gather data on the metabolic rates and physical activities of multiple mouse models in their manuscript (e.g., Figures 2C-E, Figures 3C-E, Figures 4C-E, etc.). They present the oxygen consumption and CO2 production as normalized to body weight and raised to the 0.75 power – a method previously used to report such data. However, multiple groups have raised concerns about the normalization of oxygen consumption and CO2 production to body weight, as trends regarding metabolic status can be obscured by changes in body weight. Notably, the authors find alterations in body weight in many of their models, making this a concern. Many groups now agree that analyzing metabolic data by plotting individual data points to analyze both group (i.e., phenotype) and body weight effects though ANCOVA (analysis of covariance) is the best and clearest way to present these data. See Tschop MH et al., Nat. Methods 2012 (PMID: 22205519) for more information. The authors could perform this analysis using a newly developed webtool called CalR (https://calrapp.org/) which was recently developed as a free tool for such analyses (see Mina AI et al., Cell Metab. 2018 PMID: 30017358).</p></body></sub-article><sub-article article-type="reply" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.72266.sa2</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>Essential revisions:</p><p>1) Body temperature experiments in ACE2-overexpressing mice in the HFD model</p></disp-quote><p>We have performed the body temperature experiments in ACE2-overexpressing HFD mice, which exhibited stronger thermogenesis than the control mice. This data has been integrated into the revised manuscript (Figure 3—figure supplement 1K).</p><disp-quote content-type="editor-comment"><p>2) Experiments to clarify the relationship between PKA and AKT signaling, RAS signaling and respiration</p></disp-quote><p>Many thanks for your suggestion. We have conducted the mitochondrial respiration in ACE2/Ang-(1-7) induced primary BATs treated with A779, PKA inhibitors, AKT inhibitors, PKA+AKT inhibitors, and the data has been integrated into the revised manuscript (Figure 7E, 7J, Figure 7—figure supplement 2C, 2F 2G, 2H).</p><disp-quote content-type="editor-comment"><p>Reviewer #1 (Recommendations for the authors):</p><p>1) The authors provide ample evidence that both AKT signaling and PKA signaling contribute to RAS signaling upregulation of UCP1 and mitochondrial respiration. In their model, they have the AKT and PKA pathways as unrelated inputs into mitochondrial respiration. However, primary BATs treated with PKA and AKT inhibitors seem have a similar total loss of RAS-induced oxygen consumption. This either implies that they are either part of the same pathway (not unrelated) or that AKT and PKA inhibitors are shutting off respiration in general and that this is not related to RAS-induced respiration in particular. Some experiments to clarify the relationship between PKA and AKT signaling, RAS signaling and respiration would be helpful. For example, does co-treatment with AKT and PKA inhibitors have an additive effect?</p></disp-quote><p>Thanks very much for bringing out this question. Our revised data showed that co-treatment with AKT and PKA inhibitors have an additive effect in ACE2-overexpressing primary brown adipocytes cells. The data has been integrated into the revised manuscript (Figure 7—figure supplement 2G).</p><disp-quote content-type="editor-comment"><p>Do these inhibitors have an effect on respiration independent of Ang-(1-7) treatment.</p></disp-quote><p>We performed the treatment of AKT inhibitor (MK2206) and PKA inhibitor (H89) in primary BATs with or without of Ang-(1-7), respectively. And, we analyzed the respiration differences treated with inhibitors in different groups with or without of Ang-(1-7). Combine with the above result (Figure S6G), our replenished data indicated that Ang-(1-7) treatment induced respiration at least partly through AKT and PKA signaling pathway. The data has been integrated into the revised manuscript (Figure 7E, 7J).</p><disp-quote content-type="editor-comment"><p>It may be interesting to see if Ang-(1-7) treated cells respond differently to A779 treatment than PKA or AKT inhibition in terms of mitochondrial respiration to determine the magnitude of the effect on respiration of PKAi/AKTi are similar to the effect of a RASi.</p></disp-quote><p>Thanks very much for your helpful suggestion. Our fresh data showed that there is no significant difference between A779 treatment and PKA or AKT inhibitor treatment in Ang-(1-7) treated primary brown adipocytes cells. This data indicated that A779 treatment plays similar effect to PKAi/AKTi on mitochondrial respiration in Ang-(1-7) treated cells. The data has been integrated into the revised manuscript (Figure 7—figure supplement 2H).</p><disp-quote content-type="editor-comment"><p>It may be valuable to use adipocytes from the diabetic mice and induce Ace2 in those mice, then observe how AKT and PKA inhibitors effect respiration in cells that have low basal RAS activity.</p></disp-quote><p>Thanks very much for your valuable suggestion. After hard attempts, we found that it is difficult to get high-quality mature adipocytes from db/db mice, probably because the fat cells in db/db mice are very easy to break. However, we have still tried our best to conduct the mitochondrial respiration in ACE2 overexpressed primary brown adipocytes induced by ACE2 adenovirus infect, after treated with PKA and AKT inhibitors. Due to the RAS axis in brown adipose tissue is kind of cold induced activity, we can see a lower ACE2 or Mas level if there is no cold stimulation form figure1C-1E, which indicated the relatively low basal RAS activity. So, we performed this experiment with BATs under no cold stimulation condition. Our renewed data showed that ACE2 are similar to Ang-(1-7) in terms of mitochondrial respiration on PKAi/AKTi treatment. And, AKT inhibitors but not PKA inhibitors plays obvious effect on respiration in brown adipocytes with lower basal RAS activity. While, after induce ACE2 expression in these cells, both AKT and PKA inhibitors plays significant roles on respiration. These data also imply the contribution of AKT and PKA signal pathways to RAS activity. These data have been integrated into the revised manuscript (Figure 7—figure supplement 2C, 2F).</p><disp-quote content-type="editor-comment"><p>2) Figure 2I and 3I should be quantified-though I believe that there is less UCP1 expression upon loss of Ace2 and more upon Ace2 overexpression, it is hard to tell visually and is certainly not obvious. Other histology stains, such as figures 5A, C, and E could also be quantified to provide additional certainty that the effect described is significant.</p></disp-quote><p>Thanks for your concern. We have revised these data. The related Figure 2I, 3I, 4I, 5G, 6 (A, C, E) had been quantified in the revised manuscript.</p><disp-quote content-type="editor-comment"><p>3) A critical issue is the lack of discussion and context in the introduction and discussion that places this work in context of the literature about RAS and energy expenditure. I recommend expanding the introduction and/or discussion to include this critical background. For example, previous work (PMID: 31638856 and 29066463) has found that RAS activation induced browning and energy expenditure which is surely relevant for the work described here, but it is not cited or discussed how these studies relate to the manuscript.</p></disp-quote><p>Many thanks for bring out this valuable concern. We have added the RAS and energy expenditure related background in the introduction and corresponding discussion in the revised manuscript (line 64 p. 3, line 346 p. 14).</p><disp-quote content-type="editor-comment"><p>Reviewer #2 (Recommendations for the authors):</p><p>This is a strong paper with clear experimental evidence to support most claims put forth within the abstract (as outlined in the public review). There are a handful of points that I believe the authors should consider and/or address before final publication of this study:</p><p>1. Modifying the claims in the abstract. Most claims are well supported with evidence in the paper, as outlined in the public review. Two exceptions are:</p><p>Claim 1: &quot;ACE2 knockout mice (ACE2-/y), Mas knockout mice (Mas-/-) and mice transplanted with brown adipose tissue from Mas-/- mice displayed impaired thermogenesis.&quot;</p><p>The authors show that wild type C57BL/6 mice transplanted with BAT from Mas-/- mice show metabolic impairments consistent with ACE2-/y and Mas-/- mice, but do not show data regarding their body temperature. This claim can be addressed by performing body temperature experiments similar to those performed in Figures 2F or 3F. Alternatively, the authors can restate their claim to state that &quot;mice transplanted with brown adipose tissue from Mas-/- display metabolic abnormalities consistent with those seen in the ACE2 and Mas knockout mice.&quot;</p></disp-quote><p>Thanks very much for your helpful comments. According to your suggestion, we revised this sentence to be “mice transplanted with brown adipose tissue from Mas-/- display metabolic abnormalities consistent with those seen in the ACE2 and Mas knockout mice” (line 37 p. 2).</p><disp-quote content-type="editor-comment"><p>Claim 2: &quot;…impaired thermogenesis of db/db obese diabetic mice and high-fat diet-induced obese mice were ameliorated by overexpression of ACE2 or continuous fusion of Ang-(1-7).&quot;</p><p>The authors also show that infusion of Ang-(1-7) can increase body temperature acutely after cold challenge in mice fed a high fat diet (HFD) (Figure 4H), but they do not test the effects of overexpression of ACE2 on body temperature in the HFD model. The authors can address this by either performing the body temperature experiments in ACE2-overexpressing mice in the HFD model, or reword this claim to avoid confusion over this distinction.</p></disp-quote><p>Thank you for your suggestion. We have conducted the body temperature experiments in Ace2-overexpressing HFD mice, and the data has been integrated into this version of the manuscript (Figure 3—figure supplement 1K).</p><disp-quote content-type="editor-comment"><p>2. Analyzing metabolic data according to the ANCOVA method. The authors use a TSE LabMaster to gather data on the metabolic rates and physical activities of multiple mouse models in their manuscript (e.g., Figures 2C-E, Figures 3C-E, Figures 4C-E, etc.). They present the oxygen consumption and CO2 production as normalized to body weight and raised to the 0.75 power – a method previously used to report such data. However, multiple groups have raised concerns about the normalization of oxygen consumption and CO2 production to body weight, as trends regarding metabolic status can be obscured by changes in body weight. Notably, the authors find alterations in body weight in many of their models, making this a concern. Many groups now agree that analyzing metabolic data by plotting individual data points to analyze both group (i.e., phenotype) and body weight effects though ANCOVA (analysis of covariance) is the best and clearest way to present these data. See Tschop MH et al., Nat. Methods 2012 (PMID: 22205519) for more information. The authors could perform this analysis using a newly developed webtool called CalR (https://calrapp.org/) which was recently developed as a free tool for such analyses (see Mina AI et al., Cell Metab. 2018 PMID: 30017358).</p></disp-quote><p>Thank you for your suggestion. We have revised the CLAMS data by ANCOVA on a webtool (https://calrapp.org/), and the data have been integrated into this version of the manuscript (Figure 2, 3, 4, 5, Figure 5—figure supplement 1).</p></body></sub-article></article>